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ABSTRACT
Manganese is an essential trace mineral that, at high

doses, damages the dopamine neurotransmitter system.
Evidence suggests that children may be particularly prone

to manganese neurotoxicity and may have an amplified risk
of neuronal damage. Infant formulas contain substantially

more manganese than the recommended daily allowance, so
this sub-population of infants may be at particular risk
for developing long-term behavioral deficits and neuronal

alterations. The purpose of this thesis, therefore, was to

examine the effects of low to moderate doses of manganese
(0, 250, or 750 pg per day from PD 1-21) on a comprehensive

battery of behaviors during the neonatal period,
preweanling period, and in adulthood. Additionally, this

thesis evaluated manganese-induced changes in dopamine

transporter binding sites. Manganese exposure did not
affect the appearance of developmental landmarks, nor did

it alter neonatal motor activity or olfactory orientation.
Manganese did impair neonatal motor coordination and
depressed body weight gain on PD 13-21. Manganese exposure

did not affect basal motor activity, balance, or
coordination. When tested at PD 90, however, manganeseexposed rats exhibited both reduced responding on a

iii

differential reinforcement of low rates of response

(DRL)

task and a reduction in cocaine-induced motor activity.
Moreover, early manganese exposure caused a persistent

reduction of striatal dopamine transporters. Manganese did
not alter the rewarding properties of cocaine, as measured

by the acquisition, extinction, and reinstatement of
j

conditioned place preference. When considered together, the

most parsimonious conclusion is that early manganese
exposure causes neurotoxicity, which is evidenced by short-

and long-term changes in behavior and reductions in
striatal dopamine transporters.
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CHAPTER ONE

MANGANESE AND HUMAN EXPOSURE

Introduction
Manganese is a complex trace mineral that has opposing

roles as an essential nutrient and a potential
neurotoxicant. The roles oppose because although manganese
is potentially harmful to the central nervous system,

it is

an important trace mineral required to maintain enzyme
levels and cellular transmission throughout the body

(Aschner, Vrana,

& Zheng,

1999). Most people get an

appropriate amount of manganese through dietary intake of
natural foods such as whole grains, legumes, avocados,

blueberries, and green leafy vegetables
1999).

(Aschner et al.,

Failure to maintain basal levels of manganese can

cause seizure activity and skeletal abnormalities

(Critchfield, Carl,
Lonnerdal,

& Hurley,

& Keen,

1993; Zidenberg-Cherr, Keen,

1983). However,

since sufficient

quantities of manganese are typically obtained through
diet, dietary deficiencies are secondary to the threat of
overexposure

(Aschner et al.,

1999).

The toxic effects of manganese were first identified
in 1837 by a doctor who treated five patients that inhaled

1

excessive amounts of manganese in a pyrolusite mill

(Cawte,

1985). Since then manganese poisoning has been reported

world-wide in factory alloy workers and miners
Edwards, deGeoffrou, Mergler,

Lucchini, Bergamaschi,
Mergler et al.,

(Beuter,

& Hudnell, 1999; Cawte,

Smargiassi,

Festa & Apostoli,

& Zhang,

Bellinger,

1997;

1994), as well as in individuals

accidentally exposed to manganese in drinking water

Liu,

1985;

(He,

1994; Woolf, Wright, Amarasiriwardena,

&

2002).

Behavioral and neurological manifestations of
manganese poisoning differ depending upon the length of

exposure. Early in the illness, behavioral symptoms are
similar to schizophrenia, including compulsiveness, violent
behavior, emotional instability, and hallucinations
(Aschner, 2000; Beuter et al.,
et al.,

1999; Mergler,

1999; Mergler

1994). These initial symptoms are later replaced by

extrapyramidal motor system impairments that result in
bradykinesia and dystonia (Aschner, 2000). Additionally,

manganese-intoxicated individuals gradually lose speech
capabilities: speech becomes slurred, slow and irregular,
while voices become monotone and low (Aschner, 2000).
Although the final stages of chronic manganese poisoning

closely resemble Parkinson's disease
2

(i.e., manganese

poisoning and Parkinson's disease are both characterized by

bradykinesia and widespread muscular rigidity), the
differences between the two disorders are distinct.

Specifically, manganese poisoning is characterized by less

intense resting tremor, more frequent dystonia, the
propensity to fall backwards, and inconsistent responding

to levodopa (Caine, Chu, Huang, Lu, & Olanow, 1994).

Importantly, these clinical symptoms progressively worsen
even after exposure has stopped and tissue mineral
concentrations have returned to normal levels (Hochberg et

al., 1996; Huang, Chu, Lu, Chen, & Caine, 1998; Huang, Lu,
Chu, Hochberg, Lilienfeld, Olanow, & Caine, 1993).

Manganese and Parenteral Nutrition
Supplementation
There are no reports that normal dietary intake causes

manganese poisoning; however, children and adults receiving

parenteral nutrition supplementation occasionally suffer
from manganese intoxication (Dickerson, 2001; Fell et al.,
1996; Komaki, Maisawa, Sugai, Kobayashi, & Hashimoto, 1999;

Nagatomo et al., 1999). In separate case studies, two adult
patients were admitted into hospital care following several
months of total parenteral nutrition that increased

manganese levels to. 20 pmol daily (Nagatomo et al., 1999).

3

Both patients exhibited classic symptoms of manganese
poisoning that included psychiatric and Parkinsonian

symptoms

(Nagatomo et al.,

1999).

Similar to adults, children exposed to high levels of
manganese during parenteral nutrition supplementation have

both higher levels of whole blood manganese and an excess

accumulation of manganese in certain brain regions

the basal ganglia)

(Fell et al.,

(e.g.,

1996; Komaki et al.,

1999). Children with the highest whole blood manganese

concentrations demonstrated dystonic limb movements,
abnormal posturing,
et al.,

seizure, tremor, and abnormal MRI

1996; Komaki et al.,

(Fell

1999). For children and

adults, psychiatric and behavioral dysfunctions subsided

after manganese supplementation was discontinued (Komaki et
al.,

1999).

Manganese and Environmentally
Exposed Children
Very little is known about the consequences of
manganese exposure during infancy or childhood; however,

it

is generally believed that children may be more susceptible

to manganese neurotoxicty than adults

Kostial, Kello, Jugo, Rabar,
1999; Weiss,

(Cawte,

& Maljkovic,

1985;

1978; Mergler,

1999). In China, children exposed to elevated

4

manganese in drinking water performed worse than controls
on short-term memory tasks, manual dexterity tasks, and

visuo-perceptual tasks

(He et al.,

1994). A case study in

the United States provided similar results, because a boy

inadvertently exposed to manganese through drinking water
had difficulty performing memory tasks and coordinating

rapid alternating motor movements

(Woolf et al., 2002).

Manganese and Infant Formula

It has been established that exposure to high doses of
manganese induces toxicity. Conseguently, there is

increasing concern that chronic exposure to lower amounts
of manganese may also have toxic effects
1997; Mergler,

(Lucchini et al.,

1999). Children could be at particular risk,

because a child's diet in the United States typically

exceeds the daily requirement for maintaining basal
manganese levels

(Hunt & Meacham, 2001; Milner,

1990).

For

example, the recommended daily manganese requirement for

infants ranges from 0.3 mg to 0.6 mg (Milner,

1990). In the

United States, the average dietary intake of manganese for

infants is 1.0 mg/kg per day, with 49% of the daily intake

being provided through infant foods

(Hunt & Meacham,

2001).

Importantly, commercially available infant formulas contain

5

substantially more manganese than human milk (Lonnerdal,
1994). Specifically, human milk contains approximately 3-8

pg/1 manganese, while cow milk-based formulas contain 50100 pg/1 manganese, and soy-based products contain as much

as 200-300 pg/1 manganese

(Lonnerdal,

1994). The high

manganese levels in soy-based formulas are of particular

concern, because these types of formulas are commonly
recommended for infants with protein allergies,

lactose

intolerance, or general gastrointestinal discomfort

(Lonnerdal, 1994).

Manganese and Attention Deficit/
Hyperactivity Disorder
Manganese levels in infant formulas are of particular

interest because these levels may be sufficient to cause
lasting learning disabilities and behavioral dysfunctions

associated with Attention Deficit/Hyperactivity Disorder

(ADHD)

(Cawte,

1985; Lonnerdal,

1999). Several

1994; Weiss,

lines of evidence support manganese involvement in ADHD.
Before discussing this evidence in detail, however, the
next section will provide an overview of ADHD

classifications, behavioral manifestations,
neuroimaging studies.

6

and

Attention Deficit/Hyperactivity Disorder

The prevalence of

ADHD is reported to be between 3%-

7% of school age children (American Psychiatric
Association, 1994), making this disorder one of the most

commonly diagnosed neurological disorders among children
and adolescents in the United States (Solanto, 1998) . ADHD

is characterized by persistent inattention, hyperactivity,

and/or impulsivity. These characteristics are exaggerated
and disabling in individuals with the disorder and are
inconsistent with typical behavior within the individual's

developmental period (American Psychiatric Association,
1994) .
The Diagnostic and Statistical Manual of Mental
Disorders (DSM)-IV divides behavioral symptoms into two

basic categories: inattention and hyperactivity/impulsivity

(American Psychiatric Association, 1994). These two

categories are further classified into three different

diagnostic subtypes: ADHD Predominantly Inattentive Type,
ADHD Predominantly Hyperactive-Impulsive Type, or ADHD

Combined Type. Additionally, ADHD can co-occur with other
psychiatric conditions including oppositional defiance
disorder, conduct disorder, mood disorders and

7

Tourette's/tic disorders

Slanetz,

(Goldman, Genel, Bezman,

&

1998).

Attention Deficit/Hyperactivity Disorder and
Behavioral Dysfunction
In laboratory assessments, ADHD patients display a
wide variety of behavioral dysfunctions. For example, ADHD

children exhibit impairments on short-term memory tasks

(Paule et al., 2000), complex visual memory tasks

Douglas,
tasks

(Berman,

& Bar, 1999), and on nonverbal learning and memory

(O'Toole, Abramowitz, Morris,

& Dulcan,

1997).

Inattentiveness and impulsivity interfere with the ability
of ADHD children and adults to exhibit sustained attention

(Oades,

2000; Solanto, Wender,

& Bartell,

1997; Swaab-

Barneveld et al., 2000; van der Meere, Shalev, Borger,

&

Gross-Tsur, 1995). Tasks that require participants to
withhold a previously conditioned or reinforced motor

response are difficult for children, adolescents, and

adults with ADHD (Dinn, Robbins,

& Harris,

1999; Schachar, Moto, Logan, Tannock,

2001; Nigg,

& Klim, 2000).

Additionally, ADHD children show an inability to perform

tasks that require temporal processing in order to

correctly execute a response
& McMurray,

1997; Gordon,

(Barkley, Koplowitz, Anderson,

1979; McClure & Gordon,

8

1984).

Attention Deficit/Hyperactivity Disorder and
Neuroimaging

Neuroimaging techniques consistently reveal
differences in the frontal cortex, caudate nucleus, and

globus pallidus of ADHD and nonADHD patients. Specifically,
ADHD boys, when compared to controls, have 5% less total
brain volume (Castellanos et al., 1994), 4.7% less total

cerebral volume (Castellanos et al., 1996), and less
frontal cortex volume (Filipek et al., 1997). In normal

children, the caudate nucleus exhibits a size asymmetry;
however, ADHD children do not show typical right > left
asymmetry (Castellanos et al., 1994, 1996; Mataro, Garcia-

Sanchez, Junque, Estevez-Gonzalez, & Pujol, 1997). The
degree to which caudate asymmetry is abnormal is correlated

with the inattentiveness exhibited by ADHD individuals
(Schrimsher, Billingsley, Jackson, & Moore, 2002) .

Additionally, ADHD is characterized by atypical caudate
maturation. Specifically, caudate volume normally decreases
substantially across maturation; however, the caudate
volume of children with ADHD does not show the normal

decline (Castellanos et al., 1994). Conversely, the globus
pallidus, but not the'putamen, is smaller in people
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diagnosed with ADHD (Aylward,

1996; Castellanos et al.,

1996; Giedd, Blumenthal, Molloy,

& Castellanos,

2001).

These volumetric differences are consistent with
positron emission tomography (PET)

studies and single

photon emission computerized tomography (SPECT)

studies

that demonstrate decreased metabolism in the frontal lobes

and striatum (i.e., caudate-putamen)

Zametkin, Matochik, Jons,

(Ernst,

Henrikson, Bruhn, Berner,

of ADHD patients

& Cohen,

& Nielsen,

1998; Lou,

1989; Zametkin et al.,

1990). Additionally, functional magnetic resonance imaging

(fMRI)

studies have shown decreased activation of the

frontal lobes and striatum during performance of cognitive

tasks that require inhibition of a previously reinforced
response

(Durston et al., 2003; Rubia et al.,

Teicher et al., 2000; Vaidya & Gabrieli,

1999,

2000;

1999).

Taken together, these various neuroimaging techniques
consistently demonstrate that corticostriatal circuitry is

dysfunctional in ADHD (Casey et al.,

1997; Johansen, Aase,

Meyer,

& Sagvolden, 2002; Solanto, Wender,

1997).

In addition, dysfunction of the nigrostriatal

& Bartell,

dopamine system has been implicated in motor abnormalities

associated with ADHD, while dysfunction of the
mesolimbocortical system has been implicated in altered
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reward function (Johansen et al., 2002; Sagvolden et al.,
1998).
Relationship Between Manganese Toxicity and
Attention Deficit/Hyperactivity Disorder

As mentioned previously, there is evidence suggesting
a causal relationship between manganese toxicity and ADHD.

Manganese levels in hair samples provide the first line of

evidence. Trace minerals,

including manganese,

found in

hair samples accumulate at a differential rate depending on

age and sex of the child (Collipp, Chen,
Sakai, Wariishi,

& Maitinsky,

& Nishiyama, 2000). Therefore,

1983;

it is not

surprising that children directly exposed to manganese show
increased concentrations of the mineral in hair samples

et al.,

1994; Fell et al.,

et al.,

2002).

1996; Komaki et al.,

(He

1999; Woolf

Interestingly, learning disabled children

also have elevated levels of manganese in their hair

samples, even though they have not been previously exposed
to excessive levels of the mineral
Maitinsky,

1983; Pihl & Parkes,

(Collipp, Chen,

&

1977). Consequently, these

data suggest that absorption and retention of environmental
metals may be directly related to the development of

learning disabilities as well as disruptive and hyperactive
behaviors, and emotional disturbances
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(Marlowe & Bliss,

1994; Marlowe, Schneider,

& Bliss,

1992). Not surprisingly,

manganese concentrations in hair are higher in formula-fed
infants than in breast-fed infants

(Collipp, Chen,

&

Maitinsky, 1983).
Neurobehavioral tasks also suggest that a causal

relationship may exist between manganese toxicity and ADHD
(Barkley, Koplowitz, Anderson,
al., 2003; Rubia et al.,

& McMurray,

1997; Durston et

1999, 2000; Teicher et al.,

2000;

Vaidya & Gabrieli, 1999). Although manganese neurotoxicity
has not been directly associated with function of the
frontal cortex (Calabrassi et al., 2001; Kontur & Fletcher,

1985), manganese impairs performance on neurobehavioral
tasks mediated by corticostriatal circuitry.

For example,

manganese-exposed children show memory impairment, poor

manual dexterity skills, and poor motor coordination, which
are consistent with behavioral alterations observed in ADHD
children (i.e., memory, motor, attention, and response

inhibition difficulty)

(He et al.,

1994; Woolf et al.,

2002). Combined, these results suggest that both manganese
neurotoxicity and ADHD may involve alterations of

corticostriatal functioning, which is indicated by
disinhibition of performance on neurobehavioral tasks
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(Barkley,
al.,

1997, 2003; Calabrassi et al., 2001; Casey et

1997).

Another line of evidence, provided by neuroimaging
studies, suggests that the same neural substrates are
involved in both manganese toxicity and ADHD. More

precisely, manganese toxicity and ADHD involve dopamine

system impairment of the nigrostriatal and mesolimbic
pathways.

nuclei

Manganese accumulates in the same basal ganglia

(i.e.,

striatum and globus pallidus)

that are

consistently found by neuroimaging studies to function

abnormally in ADHD (Durston et al., 2003; Erickson et al.,

2002; Lou et al.,
Gabrieli,

1989; Teicher et al., 2000; Vaidya &

1999). Abnormal functioning of the nigrostriatal

dopamine pathway is responsible for the motoric dysfunction

observed in both manganese intoxication and ADHD
2000; Aylward,
al.,

1996; Castellanos et al.,

2002; Giedd, Blumenthal, Molloy,

(Aschner,

1996; Erickson et

& Castellanos, 2001;

Johansen et al., 2002). Motoric dysfunction is most
typically expressed as impaired timing assessments, poor
motor control, hyperactivity, and impulsivity (Johansen et
al., 2002; Kadesjjo & Gillberg,

1998).
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1999; Sagvolden et al.,

Another neural substrate involved in both manganese
neurotoxicity and ADHD is the globus pallidus. Neuroimaging

studies suggest that the globus pallidus functions

abnormally in ADHD, perhaps preventing normal responding to

reinforcing or rewarding events

Douglass & Parry,
al.,

(Barkley,

1997, 2003;

1994; Johansen et al., 2002; Sagvolden et

1998). Manganese accumulation in the globus pallidus

may interrupt reward processes, because stimulation of
dopamine terminals in this brain region increases

responding for drug and food reward (Fletcher, Korth,
1998; Ono,

Sabijan,

& DeSousa, 1998; Olive & Maidment,

Nishijo,

& Nishino, 2000). Taken together, the brain areas

affected by manganese accumulation are the same areas
implicated in ADHD; therefore, it is reasonable to suggest
that manganese accumulation in the basal ganglia may cause

motoric dysfunction and reward deficiencies consistent with

symptoms observed in ADHD.

Summary
This chapter provides evidence that manganese is
neurotoxic to adults and children. Humans are primarily

exposed to manganese via environmental contamination
(Beuter et al.,

1999; Cawte,

1985; He et al.,
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1994; Mergler

et al.,

1994; Woolf et al., 2002) or orally through

parenteral nutrition

Komaki et al.,

(Dickerson, 2001; Fell et al.,

1999; Nagatomo et al.,

1996;

1999). At high doses,

manganese causes motoric and cognitive dysfunction

(Aschner,
et al.,

2000; Beuter et al.,

1999; Cawte,

1985; Mergler

1994); however, it is unclear if low doses cause

similar behavioral and cognitive symptoms. There is

increasing evidence that children may be particularly prone
to manganese neurotoxicity, because infant formulas contain

about 50% more manganese than the recommended daily
allowance

(Hunt & Meacham, 2001). Children fed these

formulas may be at risk for lasting brain changes that

result in long-term behavioral dysfunction

Lonnerdal,

1994; Mergler,

1999; Weiss,

(Cawte,

1985;

1999). Specifically,

a causal relationship may exist between manganese exposure

and ADHD (Cawte,

1985; Lonnerdal,
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1994; Weiss,

1999).

CHAPTER TWO

BASAL GANGLIA CIRCUITRY

Introduction

Based on data presented in Chapter 1, it is apparent
that manganese has toxic effects in both children and
adults. These neurotoxic effects are manifested as changes

in cognition, personality, and gross motor movement. The

accumulated evidence indicates that these changes are a

result of manganese-induced alterations of central nervous
system functioning. Manganese also affects a variety of

neurotransmitter systems, with most of the research
implicating dopamine, glutamate, and y-aminobutyric acid

(GABA). Manganese-induced changes in neurotransmission are
predominantly found in the basal ganglia; therefore, the
purpose of Chapter 2 will be to provide background
information about neurotransmitter system functioning

within the basal ganglia.

Basal Ganglia Circuitry: Structure

The basal ganglia consists of four primary nuclei: the

striatum (caudate nucleus and putamen), the globus pallidus
(internal and external segments), the substantia nigra

(pars reticulata and pars compacta), and the subthalamic
16

(Albin, Young,

nucleus

& Penny,

1989; Alexander & Crutcher,

1990; De Long, 2000) . These nuclei are involved in

mediating voluntary motor movement, oculomotor movement,
emotion, executive functioning, and motivation

Crutcher,

& DeLong, 1990; Hoover & Strick,

(Alexander,

1993,

1999).

Pathways between the cortex, basal ganglia, thalamus, and

brain stem make up the basal ganglia-thalamocortical
circuits

(see Figure 1)(Alexander et al.,

1990).

Specifically, the basal ganglia receives input from the

cortex and sends information back to the cortex via
connections with the thalamus

(Alexander et al.,

1990). The

primary input nucleus of the basal ganglia is the striatum
(Albin et al.,

1989; De Long, 2000), although the

subthalamic nucleus also receives excitatory glutamatergic
input from the cortex (Afsharpour,

1985; Alexander &

Crutcher,

1990; De Long, 2000;

1990; Carlson & Carlson,

Greenamyre, 2001; Young, Bromberg,

& Penny,

1981).

The primary output structures of the basal ganglia are
the globus pallidus internal segment and substantia nigra
pars reticulata

nuclei

(SNr), which are functionally similar

(Albin et al.,

1989; De Long, 2000). Although the
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Cortex

Figure 1. Schematic representation of basal gangliathalamocortical circuitry.
Abbreviations: GPe, globus pallidus external segment; GPi,
globus pallidus internal segment; SNr, substantia nigra
pars compacta; SNr, substantia nigra pars reticulate.
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thalamus is not considered part of the basal ganglia,

it

has an important role in basal ganglia-thalamocortical

circuitry. Specifically, the thalamus receives inhibitory
GABAergic input from the SNr and GPi and,

in turn,

sends

excitatory glutamatergic output to the cortex (Albin et
al.,

1989; Alexander & Crutcher,

1990; Carlson & Carlson,

1990; Alexander et al.,

1990; De Long, 2000; Greenamyre,

2001).
The cortex provides glutamatergic input to the

striatum which, in turn, inhibits two parallel pathways:
the direct pathway and the indirect pathway (Albin et al.,
1989; Alexander & Crutcher,

De Long,

1990; Alexander et al.,

1990;

2000). The direct pathway consists of striatal

cells projecting to the SNr and Globus pallidus internal
segment

(Albin et al.,

1989; Alexander & Crutcher,

1990;

Alexander et al., 1990; De Long, 2000). The indirect
pathway begins with striatal efferents projecting from the

striatum to the GPe, then from the GPe to the subthalamic
nucleus, and finally from the subthalamic nucleus to the

SNr and globus pallidus internal segment

1989; Alexander & Crutcher,

(Albin et al.,

1990; Alexander et al.,

De Long, 2000; Greenamyre, 2001).
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1990;

In terms of neurotransmitters, 90% of striatal neurons

are GABAergic (Alexander et al.,

O'Conner,

1990; De Long,

2000;

1998). The remaining 10% of striatal neurons,

consisting of substance P, dynorphin, enkephalin,

neurotensin, and acetylcholine interneurons, are
responsible for regulating tonic control of the striatum

(Alexander et al., 1990; De Long, 2000; O'Conner,

1998).

The neurons of the direct pathway co-release GABA,
dynorphin, and substance P in the SNr and Globus pallidus
internal segment

(Albin et al.,

1989; De Long, 2000),

whereas neurons of the indirect pathway co-release GABA,

enkephalin, and neurotensin in the globus pallidus external
segment

(GPe)

(Albin et al.,

1989; De Long, 2000) .

In

addition, GABA neurons project from the GPe to the

subthalamic nucleus

(Albin et al.,

1989; De Long,

2000).

Glutamate axons project from the subthalamic nucleus to the

SNr and Globus pallidus internal segment, which is the only
excitatory connection involving basal ganglia circuitry

(Afsharpour,
Carlson,
Bromberg,

1985; Alexander & Crutcher,

1990; Carlson &

1990; De Long, 2000; Greenamyre, 2001; Young,

& Penny,

1981).

Dopaminergic cell bodies in the SNc project to the
striatum, where they synapse on cells of the direct and
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indirect pathways

Crutcher,

(Albin et al.,

1990; Alexander et al.,

1989; Alexander &
1990; De Long,

2000).

Specifically, excitatory Di-like dopamine receptors are

located on neurons composing the direct pathway; whereas,
inhibitory D2~like dopamine receptors are located on neurons
of the indirect pathway (De Long, 2000; Gerfen,

Gerfen, Engber, Mahan, Susel, Chase, Monsma,
19 90; O'Conner,

1992;

& Sibley,

1998)".

Basal Ganglia Circuitry: Function

As just mentioned, basal ganglia-thalamocortical

circuits are involved in a variety of behavioral and motor

functions via parallel pathways that begin and end in
specific areas of the cortex and engage different areas of

the basal ganglia and thalamus
Alexander & Crutcher,

1993,

(Alexander et al.,

1990;

1990; De Long, 2000; Hoover & Strick,

1999). Activation of the direct pathway disinhibits

thalamocortical transmission. More specifically, the
inhibitory drive of striatal GABAergic projections to the
SNr and Globus pallidus internal segment,

GABA transmission to the thalamus
Alexander & Crutcher,

1990).

in turn, inhibits

(Alexander et al.,

1990;

In contrast, activation of the

indirect pathway ultimately results in increased inhibition
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of the thalamus via glutamatergic projections from the

subthalamic nucleus. In this case, increased activation of
striatal GABAergic projections to the GPe suppresses
neuronal firing, which decreases inhibitory control over

the subthalamic nucleus

& Crutcher,

(Alexander et al.,

1990; Alexander

1990). Disinhibition of the subthalamic nucleus

increases excitatory glutamatergic transmission to the SNr
and Globus pallidus internal segment, which ultimately

increases the inhibitory drive to the thalamus
et al.,

1990; Alexander & Crutcher,

(Alexander

1990). To summarize,

activation of the direct pathway disinhibits the thalamus

increasing thalamocortical transmission, while activation
of the indirect pathway causes increased inhibition of

thalamocortical neurons
Alexander et al.,

(Alexander & Crutcher,

1990;

1990; De Long, 2000).

Dopamine modulates this system. In the striatum,

Di-

like and D2-like receptors are located on different sets of

neurons and modulate both the direct and indirect pathway.
Specifically,

stimulation of striatal Di-like receptors

increases the firing rate of the striatonigral GABAergic

pathway (i.e., the direct pathway), which results in
disinhibition of the thalamus

1990; ■O'Conner,

(Gerfen, 1992; Gerfen et al.,

1998). Stimulation of striatal D2-like
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receptors reduces the firing rate of the striatopallidal
GABA pathway (i.e., the indirect pathway), which decreases

inhibition of the thalamus
1990; O'Conner,

(Gerfen, 1992; Gerfen et al.,

1998). Although striatal Dx-like and D2-like

receptors modulate different pathways, ultimately both
receptor types facilitate motor movement by reducing

inhibition of thalamocortical neurons
Gerfen,

1992; Gerfen et al.,

(De Long,

1990; O'Conner,

2000;

1998).

Since the striatum is the main input nucleus of the

basal ganglia and since the SNr and Globus pallidus

internal segment are the main output nuclei,

it is

understandable that manganese accumulation in these areas
may cause basal ganglia dysfunction. Chapter 3 will provide

information about the dopamine system, because manganese
intoxication often impairs dopamine neurotransmission

within the basal ganglia. Chapter 4 will then discuss

manganese-induced alterations in basal ganglia functioning.
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CHAPTER THREE

THE DOPAMINE SYSTEM

Introduction

As previously mentioned, dopaminergic

neurotransmission is important for motor movement and
reward processes. Since the dopamine system is implicated

in both manganese toxicity and ADHD, the next section will
include a more thorough discussion of the dopamine system.

Specifically, the section will provide information about

the effects of psychostimulant drugs on the two main
dopaminergic pathways as well as dopamine-mediated
behaviors (e.g., locomotor activity, reward seeking

behaviors, and impulsivity). The last section will describe
maturation of the dopamine system.

Dopamine Receptor Classification
Originally dopamine receptors were classified by
anatomical location and function (Clark & White, 1987).
Subsequent work has categorized dopamine receptors into
families depending upon the ability of the receptor subtype

to activate the enzyme adenylyl cyclase (Clark & White,

1987; Kebabian & Caine, 1979). Di-like receptors stimulate

adenylyl cyclase activity, while D2-like receptors either
24

inhibit or are unlinked to adenylyl cyclase activity (Clark
& White,

1987; Kebabian & Caine,

1979). On this basis, two

basic dopamine receptor families have been classified: the
Dj-like family, which consists of the Di and D5 subtypes;
and the D2-like family, which consists of the D2,

receptor subtypes

(Clark & White,

D3, and D4

1987). Di-like receptors

are located on postsynaptic terminals, whereas D2-like

receptors are present on presynaptic and postsynaptic
terminals

(Clark & White,

1987).

Dopaminergic Drugs
Psychotropic drugs that enhance the function of a

neurotransmitter system are considered agonists; whereas,

antagonists attenuate the effects of endogenous
neurotransmitters. Dopamine agonist drugs work by either

directly stimulating receptors or by indirectly altering
cellular processes in a way that increases the amount of
endogenous neurotransmitter in the synaptic cleft.

Amphetamine,

cocaine, and methylphenidate are indirect

dopamine agonists, although their mechanisms of action
differ. Amphetamine increases extracellular dopamine by

reversing the direction of the dopamine transporter, thus

increasing the release of free-floating dopamine from the
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presynaptic terminal (Heikkila, Orlansky, Mytilineou, &
Cohen, 1975; Jones, Gainetdinov, Wightman, & Caron, 1998;
Sonders, Zhu, Zahniser, Kavanaugh, & Amara, 1997). Cocaine

and methylphenidate increase extracellular dopamine levels
by blocking the dopamine transporter, thus preventing the
removal of dopamine from the synaptic cleft (Kimko, Cross,

& Abernethy, 1999; Kuhar, Ritz, & Boja, 1991; Ritz, Lamb,
Goldberg, & Kuhar, 1987; Volkow et al., 1995).

Direct dopamine receptor agonists alter dopaminergic
functioning by directly stimulating pre- and postsynaptic

receptors. For example, SKF 38393 and quinpirole
selectively stimulate Di-like and D2-like receptors,

respectively. In contrast, direct dopamine receptor

antagonists block the receptor, which prevents endogenous

or exogenous ligands from stimulating the receptor complex

Selective receptor antagonists exist for both the Di-like

(e.g., SCH 23390) and D2-like (e.g., sulpiride) receptor.

Dopamine Pathways
Behavioral responses to dopaminergic drugs are
mediated by the nigrostriatal pathway and the

mesocorticolimbic pathway. Drugs that increase dopamine
levels in the synapse (i.e., indirect agonists) initiate
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both locomotor activity and reward seeking behaviors

et al.,

1999; Costall et al.,

Wise & Hoffman,

1975; Wise & Bozarth,

(Cho
1987;

1992). Conversely, drugs that block

dopaminergic functioning decrease motoric functioning and

inhibit reward processes
Beninger,

Rompre,

(Arnt,

1997; Miller, Wickens,

1987; Josselyn, Miller,

& Beninger,

&

1990; Wise &

1989). The nigrostriatal pathway is most commonly

associated with intense and perseverative motoric effects
of dopaminergic drugs, whereas the mesocorticolimbic

pathway is most commonly associated with the rewarding

properties of dopaminergic drugs
Bozarth,

(Arnt,

1987; Wise &

1987).

Nigrostriatal Dopamine Pathway
The nigrostriatal dopamine pathway is part of the

basal ganglia and consists of cell bodies located in the
substantia nigra and projecting to the striatum. This

pathway is primarily associated with motor movement

(Arnt,

1987), because deterioration of the nigrostriatal pathway

impairs motor function and results in the behavioral
abnormalities associated with Parkinson's disease

tremor, rigidity, and bradykinesia)
& Olanow,
et al.,

(Caine, Chu, Huang, Lu,

1994; Carey, 1986; Goldberg et al.,

2003; Olanow

1996). Not surprisingly, blocking dopamine
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(e.g.,

transmission or reducing dopamine levels in the striatum
decreases motor activity. For example, depleting vesicular

stores of dopamine with reserpine reduces spontaneous
locomotor activity and stereotypy (Florin, Kuczenski,

Segal,

&

1995). Additionally, dopamine receptor antagonists

block hyperactivity induced by systemic or intrastriatal
injections of direct and indirect dopamine agonists

(Costall & Naylor,
1993; Levin,

See,

Post, Weiss,

1976; Fontana,

& South,

& Pert,

1989).

Indirect dopamine agonists differentially induce
locomotor activity and stereotypical responding depending
1999; Costall et al.,

on drug dose

(Cho et al.,

& Kuczenski,

1997). At low doses, cocaine and amphetamine

1975; Segal

increase locomotor activity due to increased dopamine
release in the nucleus accumbens

(Dickson, Lang, Hinton,

1994; Mele, Thomas,

1998). On the other

Kelly,

& Pert,

&

hand, acute treatment with a high dose of cocaine or

amphetamine increases dopamine release in the striatum and

produces stereotypy (Dickson et al.,
Martin, Boucher,

Zahr, Sikes,

1994; Waszczak,

& Stellar, 2001). Taken

together, these findings indicate that low doses of an
indirect agonist initially increases dopaminergic
transmission in the mesolimbic pathway; whereas, high doses
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preferentially activate the nigrostriatal dopamine system
(Dickson et al. ,
Kuschinsky,

1994; Mele et al.,

1998; Stahl,

Ferger,

&

1997; Waszczak et al., 2001).

Direct dopamine agonists are also capable of

increasing locomotor activity and inducing stereotypy
(Defts & Kelly, 1990; Einat & Szechtman,

Waddington,
Potter,

1987; Starr,

& Meyer,

1993; Molloy &

1988; Van Hartesveldt, Cottrell,

1992). For example, the Di-like receptor

agonist SKF 38393 increases sniffing, rearing, and

locomotion of rats habituated to the testing environment
(Molloy & Waddington,

1987); whereas,

stimulation of D2-like

receptors with quinpirole increases locomotor activity
(Einat & Szechtman,

1993; Van Hartesveldt et al.,

1992).

Combined treatment with both SKF 38393 and quinpirole
induces intense stereotypies

Waddington,

1987; Starr,

(Defts & Kelly,

1990; Molloy &

1988). Not surprisingly,

D2-like

receptor antagonists block quinpirole-induced behaviors and
Di-like receptor antagonists block SKF 38393-induced

behaviors
Starr,

(Defts & Kelly,

1990; Levin,

1988; Storey, Middlemiss,

Bednarz, Wachtel, Hjorth,

See,

& Reavill,

& Brooderson,

& South,

1989;

1995; White,

1988). The Di-like

receptor antagonist SCH 23390 also attenuates both D2-like

agonist-induced behaviors,

suggesting that the Di-like
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receptor has a "permissive" or "enabling" role in dopamine
transmission (Dali'Olio, Roncada, Vaccher, Gandolfi,
Montanaro,

1989; Defts & Kelly,

1987; Starr,

1988; White et al.,

&

1990; Molloy & Waddington,
1988).

Mesocorticolimbic Dopamine Pathway

The mesocorticolimbic dopamine pathway is composed of
dopaminergic cell bodies located in the ventral tegmental

area and projecting to the nucleus accumbens and prefrontal
cortex (see Figure 2)

Halliday,

(Ikemoto & Panksepp,

1987; Ungerstedt,

1999; Oades &

1971). Accumbal output neurons

project from the nucleus accumbens to the Globus pallidus
internal segment, and then from the Globus pallidus
internal segment to the ventral tegmental area
Murphy,

& Ikemoto,

1999; Pierce & Kalivas,

(McBride,

1997); whereas,

cortical output neurons project from the frontal cortex to
the nucleus accumbens and ventral tegmental area. Thus, the
ventral tegmental area, nucleus accumbens, Globus pallidus

internal segment, and frontal cortex make up the primary

sites mediating the reinforcing properties of dopaminergic
drugs

(Ikemoto & Panksepp,

Pierce & Kalivas,

1999; McBride et al.,

1999;

1997). Drug-induced activation of this

neural system is typically associated with subjective
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Figure 2. Schematic representation of mesocorticolimbic
system.
Abbreviations: GPi, globus pallidus internal segment.
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feelings of reward and increased behavioral activity (Wise
& Bozarth, 1987; Wise & Hoffman, 1992).

Several different behavioral paradigms demonstrate
that the mesocorticolimbic system mediates the rewarding

properties of direct and indirect dopamine agonists. These

paradigms include drug self-administration, locomotor

activity, conditioned place preference (CPP), and schedule-

controlled operant tasks (Bardo, 1998; Ikemoto & Panksepp,
1999; Mayorga, Popke, Fogle, & Paule, 2000; Paule et al.,

1999). For example, both direct and indirect dopamine
agonists can induce CPP (Carr & White, 1983; 1996; White,
Packard, & Hiroi, 1991), and are readily self-administered

by both rodents and primates (Johanson, Balster, Bonese,
1976; Neilsen, Duda, Mokler, & Moore, 1984; Woolverton,

Goldberg, & Ginos, 1984). Conversely, destroying dopamine
terminals and cell bodies of the mesocorticolimbic pathway
attenuates self-administration of dopamine agonists, blocks
CPP, and decreases both apomorphine (a direct dopamine
agonist) and amphetamine-induced locomotor activity

(Gerrits & Van Ree, 1996; Gold, Swerdlow, & Koob, 1988;
Joyce, Stinus, & Iversen, 1983; Kelly & Iversen, 1976;

Kelly,Seviour, & Iversen, 1975; Lyness, Friedle, & Moore,

1979; Pettit, Ettenberg, Bloom, & Koob, 1984; Roberts &
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Koob,

1982; Spyraki,

Fibiger,

& Phillips,

1982). The latter

finding is relevant, because locomotor hyperactivity is an
indirect measure of reward (Wise & Bozarth,

1987) .

Development of the Dopamine System
The dopamine system is not adult-like at birth, but

continues to mature during the postnatal period.

rodents, dopamine transporters,

In

Di-like and D2-like receptor

densities increase daily throughout early postnatal

development

(Galineau, Kodas, Guilloteau, Vilar,

2004; Murrin & Zeng,

1986; 1990; Rao, Molinoff,

& Chalon,
& Joyce,

1991; Tarazi & Baldessarini, 2000; Tarazi, Tomasini,

Baldessarini, 1998, Zeng, Hyttel,

& Murrin,

&

1988). The

dopamine receptor subtypes develop independently of each

other, because Di-like receptors are expressed prior to D2like receptors in the striatum, subtantia nigra,

pallidus

(Rao, Molinoff,

& Joyce,

and globus

1991). During the

periadolescent period dopamine receptors are overproduced
in the striatum and prefrontal cortex, peaking by PD 40,
and are subsequently pruned back to adult levels by PD 120

(Andersen, Thompson, Rutstein, Hostetter,
Teicher, Andersen,

& Teicher,

2000;

& Hostetter, 1995). Dopamine

transporters, on the other hand, reach peak levels between
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PD 28 - 35 and remain constant until adulthood (Galineau,

Kodas, Guilloteau, Vilar,
& Baldessarini,

& Chalon, 2004; Tarazi, Tomasini

1998).

Dopaminergic drugs have generally similar behavioral
profiles in postnatal and adult animals. For instance,

indirect dopamine agonists activate reward processes,
stimulate motor activity, and induce stereotyped behaviors
by as early as PD 2

(Barr & Lithgow,

1973; Lanier & Isaacson,

Bignami,

1986; Lal & Sourkes,

1977; Laviola, Dell'Omo, Alieva,

1992). Direct dopamine agonists

and quinpirole)

(e.g., SKF 38393

stimulate unlearned motor movements in

preweanling rats, while direct dopamine antagonists

SCH 23390 and sulpiride)

reduce motor function (Camp &

1987; McDougall, Arnold,

Rudy,

Spear,

(e.g.,

& Nonneman,

1992; Sobrian, Jones, Varghese,

1990; Moody &

& Holson, 2003).

Despite these behavior similarities, a number of drug
induced ontogenetic differences are evident.

For instance,

younger rats are less sensitive to the cataleptic effects
of dopamine antagonists

than are adult rats

Pedigo,

(Fitzgerald & Hannigan,

& Bardo, 1991).

unlike adults,

(i.e., SCH 23390 and haloperidol)

Preweanling rats

1989; Rowlett,

(PD 11 and PD 17)

are also unaffected by the irreversible

dopamine receptor antagonist N-ethoxycarbonyl-2-ethoxy-l,2
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dihydroquinoline

(EEDQ),

since administration of EEDQ did

not alter locomotor, sniffing, or grooming responses
induced by dopamine agonist drugs

Nonneman,

(McDougall, Crawford,

1992; Mestin & McDougall,

&

1993).

In some cases, adult behavioral patterns are not
expressed until the third or fourth postnatal week.

In

particular, quinpirole does not induce adult-typical
biphasic effects

(i.e., decreased activity at low doses and

increased activity at high doses) until the third or fourth
week of postnatal development
Hartesveldt, Meyer,

& Potter,

(Moody & Spear,

1994).

1992; Van

In addition,

progressively higher doses of SKF 38393 are required to

induce adult-typical grooming behavior in younger rats
(McDougall et al.,

1990; Moody & Spear,

1992). Taken

together, these data indicate that the dopamine system is
functional during early ontogeny, however, dopaminergic

drugs are capable of inducing both quantitatively and
qualitatively different behavioral effects depending on the
age of the animal

(for a review,

see Spear,

1979).

Summary
Dopaminergic drugs affect both motor activity and
reward processes by altering the functioning of the
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nigrostriatal and mesocorticolimbc pathways. The
nigrostriatal pathway is generally associated with motoric

function; whereas, the mesocorticolimbic system is
associated with locomotor activation and reward processes.

The dopamine system undergoes rapid maturation throughout
the postnatal period, a process that is responsible for

many ontogenetic differences in drug responsiveness. The
next chapter will discuss the effects of oral manganese
exposure on the dopamine system, as well as the functional
interactions between dopamine, glutamate, and GABA

neurotransmission within the basal ganglia after manganese

exposure.
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CHAPTER FOUR

MANGANESE

Introduction

The previous chapters detailed basal ganglia circuitry
as well as interactions between dopamine, glutamate, and

GABA neurons. The purpose of Chapter 4 will be to discuss
the influence of manganese on these neurotransmitter

systems. Since the behavioral manifestations of manganese
toxicity are mediated by central nervous system
functioning,

it is important to understand:

(1)

the

mechanisms responsible for transporting manganese into the

central nervous system,

(2)

the actions of manganese at the

synapse, and (3) possible explanations for manganese-

induced neurotoxicity. The last part of the chapter will
detail interactions between manganese and the dopamine,

glutamate, and GABA neurotransmitter systems.

Manganese and Central Nervous
System Functioning

The toxic effects of many compounds are often
associated with their transport mechanisms

Montgomery,

& Aposhian,

(Ingersoll,

1999). Therefore, it is important

to understand how manganese is transported into the central
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nervous system and throughout the brain. The brain is

highly permeable to manganese through transferrin and non
transferrin bound transport. In the former case, manganese
binds to transferrin and is transported across the blood-

brain barrier via transferrin receptors located on the
surface of brain capillary endothelial cells (Aschner &
Aschner, 1991; Aschner & Gannon, 1994; Davidsson,

Lonnerdal, Sandstrom, Kunz, & Keen, 1989). The greatest
percentage of manganese enters the brain independent of

transferrin binding (Takeda, Devenyi, & Connor, 1998;
Takeda, Ishiwatari, & Okada, 2000). In this case, manganese

primarily crosses into the brain as a free ion via several
different transport systems (for a review, see Takada,

2003), such as calcium channels (Drapeau & Nachshen, 1984),
or by a divalent metal transporter located on brain
capillary endothelial cells and choroidal epithelial cells
(Gunshin et al., 1997).

Once inside the brain, excess manganese accumulates in
iron-rich areas such as the striatum, nucleus accumbens,

globus pallidus, substantia nigra, ventral tegmental area
and subthalamic nucleus (Erickson, Shihabi, Aschner, &
Aschner, 2002, Fell et al., 1996; Ingersoll et al., 1999;

Komaki et al., 1999; Komura & Sakamoto, 1994; Nagatomo et
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al.,

1999; Takada, 2003). Extracellular manganese is taken

up by neurons and glial cells

(Takada,

2003). Specifically,

neurons take up transferrin-bound manganese via receptor-

mediated endocytosis and store it in synaptic vesicles
(Takada, 2003). Non-transferrin bound manganese is

sequestered in the mitochondria of astrocytes
al.,

1992; Takada, 2003; Thorley et al.,

(Aschner et

1990). Manganese

is transported via axonal transport along GABAergic

striatonigral neurons and dopaminergic nigrostriatal
neurons

(Takada,

1998).

Taken together, manganese is

readily transported into and throughout the brain where it
is stored in both neurons and glial cells.

Manganese Exposure During Development

Neonatal brains accumulate manganese more extensively
than adult brains and are less efficient at maintaining
homeostatic levels

(Ballatori, Miles,

Doorman et al., 2000; Fechter,
Rabar,

& Maljkovic,

1980; Takada,

& Clarkson,

1999; Kostial, Kello, Jugo,

1978; Rehnberg, Hein, Carter,

Ishiwatari,

1987;

& Okada,

& Laskey,

1999). A possible

explanation for excess manganese accumulation is that the
biliary system of neonatal rats has not fully developed,
thus preventing manganese from being excreted in bile
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(Ballatori et al.,

1987; Miller, Cotzias,

& Everet,

1975).

Alternatively, neonatal rats may have an underdeveloped
gastrointestinal tract that potentiates manganese

absorption (Kostial et al.,

Laskey,

1978; Rehnberg, Hein, Carter,

&

1985). Elevated blood transferrin levels in

neonatal rats may also have an impact

(Roskams & Connor,

1994), because increased manganese transport across an
incomplete blood-brain barrier would result in excess brain

manganese

(Miller et al.,

1975).

Manganese, Synaptic Transmission,
and Neurotoxicity
The previous sections demonstrated that manganese can

accumulate in both neurons and glial cells, with the effect
being magnified in young rats. Excess manganese can
interfere with synaptic transmission through various

mechanisms. First, manganese located in the synaptic cleft
may modulate the release of glutamate, aspartate, and GABA

from neuron terminals

(Tanaka, 2002). Second, manganese can

potentiate neurotransmitter release by substituting for

calcium in the exocytotic process

(Drapeau & Nachshen,

1984). Third, chronic manganese increases the frequency and
amplitude of spontaneous excitatory postsynaptic potentials

(Centonze, Gubellini, Bernardi,
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& Calabresi, 2001) .

Fourth,

manganese potentiates glutamate-induced activation of NMDA

receptors located on nigrostriatal dopamine terminals

(Cuesta de Di Zio et al.,

1995). Taken together, it is

clear that manganese can alter neurotransmission of

dopamine, glutamate, and GABA neurons in multiple ways.
Although it is known that manganese disrupts
neurotransmission, the precise mechanism by which manganese
causes neuronal damage is uncertain. Even so, most
researchers studying manganese toxicity have focused on

three potential mechanisms involving astrocytes

al.,

(Aschner et

1992; Hazell, 2002), extracellular glutamate

Liao, 2002), and oxidative stress

(Chen & Liao,

(Chen &

2002).

Astrocytes may be responsible for manganese-induced

neurotoxicity, because mitochondria in glial cells store
excess manganese

(Aschner et al.,

1992; Tholey et al.,

1987). The excess manganese may disturb astrocytic

functioning, thus preventing astrocytes from providing
neurons with the necessary substrates for energy and

neurotransmitter metabolism (Hazell, 2002; Tomas-Camardiel
et al., 2002; Zwingmann, Leibfritz,

& Hazell,

2003).

An additional possibility is that manganese may

initiate excitotoxicity by indirectly increasing

extracellular glutamate. Evidence supporting this idea
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includes the finding that manganese treatment decreases the
uptake of glutamate in cultured astrocytes, thereby

increasing extracellular glutamate

(Chen & Liao, 2002) .

Moreover, intrastriatal injections of manganese cause
lesions similar to those produced by N-methyl-D-aspartate

agonists

(NMDA)

Beal,

(Brouillet, Shinobu, McGarvey, Hochberg,

&

1993). The latter finding is more than coincidental,

because it is possible to prevent manganese-induced lesions
by either destroying corticostriatal glutamatergic input

fibers or pretreating rats with NMDA receptor antagonists
(Brouillet et al.,

1993).

Lastly, it is possible that manganese can cause
neurotoxicity by inducing oxidative stress and free radical

formation
et al.,

(Chen & Liao, 2002; Desole et al.,

1995; Dobson

2003). Both of these processes can be initiated by

excess amounts of extracellular dopamine and glutamate,

which is characteristic of early manganese poisoning

(Chandra & Shukla,

1981; Chen & Liao, 2002; Desole et al.,

1995; Dorman et al., 2000). More specifically,

dopamine is

catabolized through oxidation, thus increasing free radical
formation

(Cadet & Brannock,

1998). Consequently,

free

radicals stimulate the release of additional glutamate

which potentiates glutamate excitotoxicity (Cadet &
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Brannock,

1998; Wolf, Xue, Li,

& Wavak, 2000).

Additionally, manganese directly induces the oxidation of

dopamine, resulting in additional oxidative damage
Liao, 2002; Desole et al.,

(Chen &

1995; Takeda, 2003).

Manganese and Neurotransmitter Systems
Dopamine
Manganese affects dopamine levels complexly, depending

upon the length of exposure and the age of the animals.

Exposing male rats to manganese
30,

(1 mg/ml of water)

for 15,

60, or 240 days increased striatal dopamine levels;

whereas, exposing rats to the same dose for 300 and 360
days reduced striatal dopamine levels

(Chandra & Shukla,

1981). Consistent with the latter finding, chronic exposure
to manganese

(2 g/kg of food)

for 365 days decreased

striatal dopamine (Komura & Sakamoto, 1992). Taken

together, these findings suggest that manganese exposure of
less than 300 days increases striatal dopamine levels,
whereas manganese exposure for more than 300 days is

associated with striatal dopamine depletions
Shukla,

(Chandra &

1981). In contrast, a number of other researchers

have reported that even a brief exposure to manganese can

decrease dopamine levels. For example,
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subchronic exposure

to manganese

(100 mg/kg orally twice a day for 7

consecutive days) decreased dopamine levels in the
brainstems of 90- and 120-day-old rats

(Desole et al.,

1994a), and decreased striatal dopamine levels in 120-, but
not 90-, day-old rats

(Desole et al.,

1994b).

The effects of manganese exposure on preweanling rats
is even more uncertain, because neonatal manganese exposure

has been reported to increase

(Dorman et al.,

2000),

decrease (Tran, Chowanadisai, Crinella, Chicz-DeMet,
Lonnerdal,

2002; Tran, Chowanadisai, Lonnerdal, Le,

Chicz-DeMet,

levels

&

Parker,

& Crinella, 2002), or not affect dopamine

(Kontur & Flechter,

1985; Pappas et al.,

1997) .

Differences in age, dose, and type of dosing method may

account for these discrepant results. For example, dopamine
levels were enhanced after high-dose oral exposure
50 mg/kg/day)

on PD 1-21

(Dorman et al., 2000), but not

after low-dose oral exposure
same days

(25 or

(Kontur & Flechter,

(25 or 50 pg per day) on the

1985). Age may also influence

neurotoxicity because low-dose oral manganese treatment
(250 or 500 pg per day)

on PD 1-21 resulted in decreased

striatal dopamine levels when assayed at PD 40 or PD 62,

but not at PD 21

(Kontur & Flechter, 1985; Tran,

Chowanadisai, Crinella, Chicz-DeMet,
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& Lonnerdal,

2002;

Tran, Chowanadisai, Lonnerdal, Le,

Parker, Chicz-DeMet,

&

Crinella, 2002). Interestingly, striatal dopamine levels
were not affected when manganese was administered in

drinking water prenatally, postnatally, or during early
adolescence

(Pappas et al.,

1997).

In addition to altering dopamine levels, manganese

affects the functioning of dopamine autoreceptors, and
presynaptic and postsynaptic D2-like receptors. Manganese

disrupts the functioning of dopaminergic autoreceptors in

the striatum resulting in a loss of autoreceptor control
over dopamine release

Suarez-Roca,

(Cuesta de Di Zio, Gomez, Bonilla,

&

1995). Additionally, manganese-exposed rats

exhibit enhanced striatal D2-like receptor binding without
any observable changes in dopamine levels or dopamine

metabolites

(Seth & Chandra,

1984). This effect is only

seen in adult rats, because neonatal manganese exposure

reduces striatal D2-like receptor binding (Seth & Chandra,
1984). Manganese also alters the functioning of D2-like
dopamine receptors in the striatum, because quinpirole-

induced excitatory postsynaptic potentials were depressed
in manganese-treated rats

(Calabresi et al.,

2001).

Manganese may damage dopamine transporters. In
addition to removing endogenous dopamine and reactive
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dopamine metabolites from the synaptic cleft, dopamine
transporters bring exogenous compounds into the synaptic
terminal, which renders the dopamine transporter vulnerable

to damage by multiple toxins (Miller, Gainetdinow, Levy, &

Caron, 1999). In particular, it is known that manganese is

capable of entering the neuron via dopamine transporters,
because cocaine pretreatment blocks manganese absorption

(Ingersoll, Montgomery, & Aposhian, 1999). Early manganese
exposure may increase the vulnerability of the dopamine

transporter and cause damage to dopamine nerve terminals.
Consistent with this idea, neonatal exposure to
environmental toxins and stimulant drugs affects dopamine

transporters. Specifically, cocaine and heptachlor increase

dopamine transporter binding, whereas neonatal exposure to

PCBs reduce the number of dopamine transporters (Caudle,

Richardson, & Miller, 2004; Fang, & Ronnekleiv, 1999;
Purkerson-Parker, McDaniel, & Moser, 2001; Richardson, &
Miller, 2004). It has yet to be determined if early

manganese exposure causes lasting changes to dopamine
transporters that persist into adulthood.

Glutamate and y-aminobutyric Acid
Previous chapters discussed how dopamine, glutamate,

and GABA neurons interact in the basal ganglia. Therefore,
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it is not surprising that manganese alters glutamate and
GABA system functioning, as well as dopaminergic
functioning. Several research reports indicate that GABA
neurotransmission is altered by manganese exposure

(Bonilla,
Murray,

1978; Erikson & Aschner,

2003; Gianutsos &

1982; Gwiazda, Lee, Sheridan,

Duhart, Newport,

1999). Specifically,

& Ali,

Slikker,

& Smith, 2002; Lipe,

long

term exposure to high doses of manganese in drinking water

(10 mg/ml for 60 days), food (4% of total diet for 180

(80 mg/kg,

days), or subcutaneous injection

alternating

days for 3 weeks) enhanced GABA levels in the striatum,

while reducing dopamine content
Murray,

(Bonilla,

1977; Gianutsos &

1982). Consistent with these findings, repeated

treatment with low doses

(4.8 mg/kg,

3 times a week for 5

weeks) of manganese increased striatal GABA levels, while
leaving dopamine unaffected (Gwiazda, Lee, Sheridan &
Smith, 2002). However, the effects of manganese are not

uniform, because a manganese regimen of 6 mg/kg

consecutive days)
levels

caused a decrease in whole brain GABA

(Chandra, Malhotra,

manganese

(for 30

& Shulka,

1982). Likewise,

(200 nM) perfused into the striatum and

hippocampus during in vivo microdialysis also reduced GABA
concentrations

(Takeda, Sotogaku,
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& Oku, 2002,

2003) . When

these results are considered together it appears that

manganese differentially affects GABA neurotransmission
depending on route of administration, dose, and brain areas

investigated.
Researchers have also examined the effects of

manganese on glutamate neurotransmission. This is of
particular importance because extracellular glutamate

causes excitotoxicity, which is one of the mechanisms
responsible for manganese-induced neurotoxicity (Brouillet

et al., 1993). Specifically, manganese increases

extracellular glutamate by altering the rate of glutamate

uptake by astrocytes (Chen & Liao, 2002; Erikson & Aschner,

2002). In particular, manganese down-regulates
glutamate/aspartate (GLAST) transporter expression, thus
reducing the ability of astrocytes to remove extracellular

glutamate (Erikson & Aschner, 2002).

Manganese also disrupts glutamate and GABA
neurotransmission in developing rats (Erikson, Zakariya,
Shihabi, Aschner, & Aschner, 2002; Lipe et al., 1999).

Exposing weanling rats to high doses of manganese (20 mg/kg
via oral gavage for 30 days) increased striatal GABA levels
(Lipe et al., 1999). However, exposing iron-deficient

weanling rats to manganese (100 mg/kg in food for 42 days)
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decreased GABA levels in both the striatum and globus

pallidus, while increasing glutamate in the cortex
et al., 2002).

(Erikson

In the latter study, manganese

concentrations were negatively correlated with striatal
GABA levels

(Erikson et al.,

2002). These manganese-induced

effects have only been observed in iron-deficient weanling
rats,

so it has yet to be determined whether similar

effects will occur after neonatal or perinatal manganese
exposure in non-iron deprived rats.

Interaction Between Manganese and the Dopamine,
Glutamate, and Y_amin°kutyric Acid
Neurotransmitter Systems

It has been well established that long-term or highdose exposure to manganese causes dopamine depletion in the

nigrostriatal pathway. However, prior to actual cell loss
or degradation of this pathway, neuropsychiatric symptoms
and neuromotor impairment are exhibited by humans, non

human primates, and rodents

(Aschner, 2000; Beuter et al.,

1999; Dorman et al., 2000; Mergler, 1999; Mergler et al.,
1994; Newland & Weiss,
Gwiazda,

& Smith,

1999; Olanow et al.,

1996; Witholt,

2000). For this reason it is possible

that the initial motor impairment occurring after manganese

exposure may be caused by GABAergic, rather than
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dopaminergic, dysfunction (Chandra, Malhotra,

& Shukla,

1982; Erikson & Aschner, 2003; Gwiazda et al., 2002;

Witholt et al., 2000). In light of this, Erikson and
Aschner

(2003) have suggested that disruptions of GABAergic

and glutamatergic neurotransmission may precede disruptions

of the dopaminergic system. Moreover, neurochemical

alterations of glutamate and GABA may be primarily
responsible for the behavioral manifestations of early
manganese toxicity (Erikson & Aschner, 2003). Specifically,
manganese exposure

(4.8 mg/kg, 3 times a week for 5 weeks)

increased striatal GABA levels, suppressed overall motor
activity, and impaired neuromuscular coordination without

altering dopamine or dopamine metabolites

(Gwiazda et al.,

2002; Witholt et al., 2000).

The interaction between the dopamine, glutamate, and
GABA neurotransmitter systems involves basal ganglia
circuitry (see Figure 3). For example, manganese increases

cortical glutamatergic input to the striatum (Brouillet et

al.,
1995)

1993; Calabresi et al.,

2001; Cuesta de Di Zio et al.,

and decreases inhibitory GABA input to the substantia

nigra and globus pallidus

(Erikson et al., 2002). Manganese

accumulation in the globus pallidus also decreases the
firing rate of GABA neurons projecting to the subthalamic
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Cortex

Figure 3. Schematic representation of basal ganglia
circuitry during manganese exposure (Adapted from Erikson &
Aschner, 2003; Verity, 1999). Bold lines represent an
increase in transmission; whereas, broken lines represent a
decrease in transmission.

51

nucleus

(Erikson & Aschner,

2003). As a result,

glutamate

neurotransmission from the subthalamic nucleus to the
substantia nigra is disinhibited (Erikson & Aschner,

2003)

In summary, high-dose or long-term manganese exposure

disrupts the functioning of dopaminergic, glutamatergic,
and GABAergic neurons.

Interestingly,

low-dose manganese

exposure can alter glutamate and GABA levels without
changing dopamine levels. Therefore, Erikson and Aschner
(2003)

suggest that manganese-induced alterations in

glutamate and GABA neurotransmission may precede changes
involving dopamine neurons.
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CHAPTER FIVE
MANGANESE AND BEHAVIORAL ALTERATIONS

Introduction
The previous chapters described manganese toxicity in

humans, the function of the basal ganglia, dopaminergic

transmission, and the effects of manganese within the
central nervous system. Not surprisingly, manganese also
causes behavioral alterations in laboratory animals.

Chapter 5 will discuss behavioral changes in neonatal and
adult rats that result from manganese exposure.

Manganese and Locomotor Activity
Since manganese toxicity is associated with

dysfunctions of the dopamine neurotransmitter system,
research has focused on alterations in spontaneous
locomotor activity as a measure of manganese toxicity. The

effects of manganese on motoric function are not uniform,
however, because there are conflicting reports regarding

manganese exposure and locomotor activity (Dorman et al.,

2000; Normandin et al., 2002; Salehi et al., 2003).
example,

inhaled manganese

For

(300 pg/m3 a day for 13 weeks)

has been alternately reported to leave motoric activity
unaffected or increase motoric activity (Normandin et al.,
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2002; Salehi et al., 2003). Likewise, spontaneous locomotor
activity has been reported to decline after exposure to

manganese during the neonatal period or in adulthood
(Talavera, Arcaya, Giraldoth, Suarez, & Bonilla, 1999;
Torrente, Colomina, & Domingo, 2002). Conversely, locomotor

activity of 17-day-old rats has been reported to increase
after perinatal exposure to manganese (Pappas et al., 1997)
and enhanced locomotor activity was evident in adult rats
exposed to manganese during adolescence (Calabresi et al.,
2000; Nachtman, Tubben & Commissaris, 1986).

Manganese poisoning progresses in stages, so it is
possible that these discrepant behavioral effects reflect

manganese-induced changes in underlying neural systems. For
example, manganese administered in drinking water increases

motor activity during the first month of exposure, followed

by five months of no change, and then causes a decrease in
locomotor activity (Bonilla, 1984). It is possible that the
initial increase in locomotor activity is due to the
increased dopamine levels often associated with short-term

manganese exposure (Bonilla, 1984; Chandra & Shukla, 1981;
Nachtman et al., 1986). The subsequent decline in locomotor
activity is consistent with nigrostriatal dopamine
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depletions often associated with long-term exposure
(Bonilla,

1984; Chandra & Shukla,

1981).

Because manganese alters neuronal functioning at a
synaptic level, a pharmacological challenge may be

necessary to "unmask" manganese-induced motoric deficits

that are not observed during basal conditions
Buelke-Sam, Nelson, Reiter,

Sobotka, Tilson,

1985; Hughes & Sparber, 1978; U.S. EPA,

exposing rats to manganese

(Adams,

& Nelson,

1995).

For example,

(10 mg/ml in drinking water)

from conception to PD 80 did not affect locomotor activity;
however,

an amphetamine challenge

(1 mg/kg) attenuated

locomotor activity in manganese-exposed rats

(Leung et al.,

1982). In another study, amphetamine potentiated manganese-

induced locomotor activity. In particular, manganeseexposed rats

(1 mg/kg in drinking water for 14-29 weeks)

challenged with amphetamine (1.25 mg/kg)

exhibited enhanced

locomotor activity relative to saline-challenged rats

(Nachtman et al.,

1986).

Interestingly, this manganese-

induced effect declined in magnitude by 29 weeks and

dissipated with subsequent testing (Nachtman et al.,
Taken together, these data indicate that amphetamine
differentially affects the neuronal functioning of
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1986).

manganese-exposed rats by alternately potentiating and
suppressing dopamine-mediated locomotor activity.

Manganese and Learning
Several different learning paradigms have been used to

investigate the effects of manganese on learning and
memory. For example, neonatal manganese exposure impaired
performance on a passive avoidance task at PD 32, but not

at PD 21, or in adulthood (Dorman et al., 2000; Torente et
al., 2002; Tran, Chowanadisai, Lonnerdal, Le,
Chicz-DeMet,

Parker,

& Crinella, 2002). In adult rats, manganese

also impaired the acquisition of an avoidance response to

both conditioned and unconditioned stimuli

Lazriev,

(Shukakidze,

& Mitagvwriya, 2003).

Manganese also influences performance on maze
learning, however the effects are dependent upon age of

exposure and manganese regimen. Rats exposed neonatally to
manganese were unaffected on the elevated plus maze, Morris

water maze, or radial arm maze

(Pappas et al.,

1997).

During adolescence, acquisition rates on the radial arm
maze were similar for manganese-exposed (20 mg/ml in water

for 10 weeks) and control rats,

indicating that manganese

does not affect spatial learning (Calabrasi et al., 2001).
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However, manganese-exposed adolescent rats correctly

completed an eight arm radial maze faster than controls,
thus indicating that manganese causes motor impairments
rather than cognitive dysfunction (Calabrasi et al., 2001).

Adult rats exposed chronically to high doses of manganese
(20 or 50 mg/kg in drinking water for 30 days) prior to
maze training showed severe learning impairment and motoric

dysfunction on a multipath maze (Shukakidze et al., 2003).

Manganese and Functional Observational Batteries
A functional observational battery (FOB) is comprised

of a variety of assessments to evaluate developmental
landmarks, sensory and motor development, and autonomic

functioning (U.S. EPA, 1995; Verity, 1997). Exposing rats

to manganese during gestation (1 or 2 mg/kg/day, s.c.)
caused a subsequent increase in infant mortality between PD
0 and PD 4, and delayed both eye opening and incisor

eruption (Torrente et al., 2002). Manganese treatment did

not affect surface righting, although it did decrease the
latency to complete a 180° turn on a negative geotaxis task
(Torrente et al., 2002). On an olfactory discrimination
task, manganese increased the latency for 10-day-old rats

to find their home bedding (Tran, Chowanadisai, Crinella,
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Chicz-DeMet,

& Lonnerdal, 2002). Taken together, these data

indicate that early manganese exposure is capable of

interfering with normal physical,

sensory, and motor

development.

While FOBs are primarily used in developmental
neurotoxicological studies, adult female rats exposed
chronically to low doses of manganese

(4.8 mg/kg,

3 days a

week for 5 weeks) exhibited increased motor activity,

rearing, balance beam falls and general balance impairment,
as well as gait abnormalities and enhanced behavioral

arousal

(Witholt, Gwiazda,

& Smith, 2000). In contrast,

adult male rats exposed to manganese

(0, 25,

or 50 mg/kg)

for 18 consecutive days did not show any differences on a
FOB (Dorman et al., 2000). Taken together, these results
indicate that manganese exposure regimen,

sex,

and age at

testing may impact the behavioral manifestations of

manganese toxicity.

Summary
This chapter detailed behavioral alterations that
result from manganese exposure. The most intriguing
findings include: 1) the effects of early manganese

exposure

(gestational through adolescents)

58

on physical,

sensory, and motor development, and 2) manganese-induced
changes in responsiveness to dopamine agonist drugs.
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CHAPTER SIX

DIFFERENTIAL REINFORCEMENT OF
LOW RATES OF RESPONDING

Introduction
Schedule controlled operant behaviors are often used
to assess learning and memory processes. Performance on

these tasks depends on training and motivational variables

which may be disrupted by environmental neurotoxicants
(U.S. EPA,

1995). Alterations of typical response patterns

associated with specific reinforcement schedules are

potential evidence of a neurotoxic effect

(U.S. EPA,

1995)

These alterations in operant responding may include

increases in overall response rates, temporal processing,
and response distributions. The differential reinforcement
of low rate responding (DRL)

task is a response contingent

behavioral task designed to assess both impulsivity and
temporal processing. The next chapter will provide

information about the DRL task, neural substrates involved
in' DRL performance, and the role of dopamine in DRL
performance.
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Differential Reinforcement of
Low Rates of Responding

The DRL reinforcement schedule is an interval

reinforcement schedule which requires that a specified
amount of time pass before reinforcement is available. The
DRL schedule differs from a traditional fixed interval

schedule because premature responses reset the fixed
interval.

It often takes multiple trials to perform this

task accurately because there are both extinction and

partial reinforcement components to DRL learning
1975; Zeigler,

1977).

(Reynolds,

For example, at the beginning of

training the majority of responses are not reinforced,
therefore operant responding begins to extinguish. However,

before the behavior is extinguished, a response generated

after the fixed interval will be reinforced. This
reinforced response will generate increased responding.

This pattern will be repeated until the organism learns
that reinforcement is only available after a fixed interval
of time has passed between responses

(Reynolds,

1975).

In neurotoxicity or drug studies, performance on a DRL

schedule is primarily defined by overall response rates and
response patterns. Overall response rates on a DRL schedule

can be assessed by general endpoint measurements,
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including: total bar press responses, number of

reinforcements received, and efficiency scores
(reinforcements received/bar press responses). However,

while these measures can provide general information about

performance, subtle differences in response patterns often
go unnoticed (Thompson & Grabowski,

1972). In neurotoxicity

studies, examining response patterns is important because

it is necessary to differentiate between rapid bar press
responses

(burst responses) and mistimed responses.

Typically, response patterns are identified by an

analysis of inter-response-time
Grabowski,

1972).

(IRT)

(Thompson &

IRT is the amount of time occurring

between operant responses

(Thompson & Grabowski,

1972).

In

an IRT analysis, operant responses are categorized into

time bins

(see Figure 4).

For example, bin 1 represents the

number of bar press responses occurring between 0-2 s; bin

2 represents bar press responses occurring between 2-4 s;
and bin 3 represents bar press responses occurring between

4-6 s, etc. The typical IRT distribution on a DRL
reinforcement schedule is bimodal. The first peak in the
distribution represents short IRTs

(i.e., bin 1 responses).

The second peak occurs in the time bin representing
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b1

b2

b3

b4

b5

b6

b7

b8

b9

b10

b11

b12

b13

b14

b15

Distribution Of Intertrial Response Time

Figure 4. Sample of a traditional differential
reinforcement of low rates of responding (DRL) intertrial
response time (IRT) distribution. Typical performance has a
bimodal response pattern with peak bar press responding
being represented in the first time bin (i.e., bi) and
reinforcement time bin (i.e., b9).
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reinforced responses (bin 9, in this case). Alterations in

the characteristic IRT distribution of a DRL schedule may

indicate behavioral abnormalities. In particular, increased
bar presses in bin 1 is indicative of increased impulsivity

(Nalwa & Rao, 1985; 2001; Sokolowski & Salamone, 1994;

Wiley, Compton, & Golden, 2000). Additionally, changes in
the number of bar press responses occurring immediately
prior to reinforcement (i.e., bin 6-8, in this case) or
after reinforcement (i.e., bin 10-12, in this case)

indicates a disruption of temporal processing (Compton et
al., 2001; Wiley, Compton, & Golden, 2000).

Neural Substrates Involved in Differential
Reinforcement of Low Rates of
Responding Performance

Optimal performance on the DRL task requires response
inhibition and accurate timing ability, both of which

involve corticostriatal circuitry. Response inhibition is
mediated by the prefrontal cortex, since damage to this
area typically increases impulsive responding (Broersen &
Uylings,

1999; Christakou, Robbins,

& Everitt, 2001;

Granon, Hardouin, Courtiere, & Poucet, 1998). Not

surprisingly, lesions to the prefrontal cortex and striatum

increase impulsive responding on a DRL schedule (Dunnett &
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Iverson,

1982; Kolb, Nonneman,

1985, 2001; Numan, Seifert,
Divac,

& Singh, 1974; Nalwa & Rao,

& Lubar,

1975; Schmaltz & Isaacson,

1975; Rosenkilde &

1967). Taken together,

these studies imply that intact corticostriatal circuitry

is necessary to inhibit impulsive responding on a DRL task.
DRL performance also requires accurate estimation of

time duration and this complex process involves basal
ganglia-thalamocortical circuitry (Matell & Meek,

Meek,

2000;

1996; Meek & Benson, 2002). Human neuroimaging

studies show increased activation of basal gangliathalamocortical circuitry during the performance of timing
tasks

(Rao, Harrington, Haaland, Bobholz, Cox,

1997; Rao, Mayer,

& Harrington,

& Binder,

2001). Within the basal

ganglia, the nigrostriatal pathway is particularly
important because dopamine cell loss in the substantia

nigra disrupts temporal processing (Malapani, Rakitin,
Levy, Meek,

Deweer, Dubois,

& Gibbon,

1998). Since DRL

performance requires both response inhibition and temporal

processing, it is not surprising that the striatum mediates
DRL performance via cortical connections
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(Neil,

1967).

The Role of Dopamine in Differential
Reinforcement of Low Rates of
Responding Performance

The dopamine system appears to be important for DRL
performance because enhancing or depressing dopamine
neurotransmission alters overall response rates and

temporal processing. Specifically,

6-OHDA lesions of the

frontal cortex increases impulsive responding,

as indicated

by an increase in bin 1 responses on the DRL task
(Sokolowski & Salamone, 1994). Likewise,

6-OHDA lesions of

the striatum cause both an increase in impulsive responding
(i.e., bin 1 responses)
efficiency scores

and a decrease in overall

(Dunnett & Iverson,

1982). Dopamine

agonists speed up DRL performance (i.e., they shift the

peak IRT bin to the left), while dopamine antagonists slow
down DRL performance
the right)

(i.e., they shift the peak IRT bin to

(Paule et al.,

1999). More precisely, treatment

with various indirect dopamine agonists

(i.e.,

methamphetamine, amphetamine, and methylphenidate)
decreases efficiency scores, increases the number of short

IRTs, and increases overall responses
Oglesby,

1980; Paule et al.,

2000; Seiden, Andresen,

(Bizot,

1998; Emmett-

1999; Sabol, Richards,

& Mac Phail,

& Yung,

1979). These effects

appear to be mediated by dopamine receptors located in the
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striatum (Neil,

1967).

In contrast, dopamine antagonists

(e.g., haloperidol, clozapine, and pimozide)

decrease

response rates, which results in longer IRTs

(Britton &

Koob,

1989; Compton et al., 2001; Seiden,

Shaughnessy,

Dahms,

&

1985; Wiley et al., 2000).

Differential Reinforcement of Low Rates of
Responding Performance and
Environmental Toxins

The adverse effects of environmental toxins can be
identified using the DRL task. Specifically,
organophosphates, trimethyltin, and lead acetate all

disrupt DRL performance
Grant,
Rice,

& Kimmell,
1992; Rice,

(Bizot,

1998; Dietz, McMillan,

1978; McDonough, Smith,

& Gilbert,

1985).

& Smith,

1986;

In the former case, the

number of overall responses and the number of

reinforcements earned on the DRL task were reduced after
exposure to organophosphates
al.,

1986; Wenger et al.,

(Bizot,

1998; McDonough et

1985). Likewise,.trimethyltin,

which impairs cellular functioning, transiently alters DRL
performance at low doses and permanently decreases DRL
responding at high doses
Baisden,

& Nonneman,

(Wenger et al.,

1985; Woodruff,

1991). Lead acetate, a mineral that

alters dopaminergic functioning, also alters DRL
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performance in rodents and non-human primates

al.,

1978; Jason,

Gilbert,

1985).

& Kellog,

(Dietz et

1981; Rice, 1992; Rice,

&

In particular, neonatal lead exposure

increases the number of bar presses with short IRTs and
decreases the number of reinforcements earned

al.,

1978; Rice,

1992; Rice & Gilbert,

(Dietz et

1985). Therefore,

while no studies have investigated the ability of manganese
to alter DRL performance, there is an abundance of evidence

suggesting that a variety of neurotoxicants,

some of which

affect the dopamine system, alter DRL performance.

Summary
The DRL task is a sensitive measure of impulsivity and
temporal processing

(Paule et al.,

Sokolowski & Salamone,

1999; Reynolds,

1994; Thompson & Grabowski,

1975;

1972).

Intact functioning of the prefrontal cortex and basal
ganglia is necessary for successful performance on the DRL

task, thus this task is sensitive to alterations of

dopamine neurotransmission

(Compton et al., 2001; Neil,

1967; Sokolowski & Salamone,

1994). Not surprisingly,

neurotoxin-induced alterations of the dopamine system

adversely affect DRL performance.

68

CHAPTER SEVEN
CONDITIONED PLACE PREFERENCE

Introduction
Chapter 6 discussed the use of the DRL task to measure

neurotoxicity because environmental toxins often affect

impulsivity and temporal. processing. It is also possible
that environmental neurotoxicants are capable of disrupting

reward functioning. At present, it is uncertain whether
neonatal manganese exposure alters the rewarding properties

of psychostimulant drugs. Chapter 7 will discuss the CPP

paradigm, the neural substrates mediating cocaine place
preference, and the effects of environmental toxins on CPP.

Conditioned Place Preference

In the CPP paradigm, the animal learns an association
between a particular compartment of a testing apparatus and

the rewarding properties of food, water or a drug (Beninger
& Miller, 1998; Wise & Hoffman, 1992). In most CPP studies

the environmental context becomes associated with the

rewarding aspects of a particular drug. The associations
formed during the CPP procedure are based on Pavlovian
learning principles. Specifically, a previously neutral

stimulus (i.e., the testing compartment) is paired with an
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unconditioned stimulus (i.e., the drug). After repeated
pairings of the testing compartment (conditioned stimulus)

with the drug (unconditioned stimulus), the animal forms an

association between the two. In the case of CPP, the animal

prefers to spend time in the drug-paired compartment
because the test compartment has come to elicit feelings of

reward or drug craving (Beninger & Miller, 1998; Wise &

Hoffman, 1992).

Neural Substrates Involved in Cocaine-Induced
Conditioned Place Preference
Cocaine- and amphetamine-induced CPP involves multiple
neural substrates including the nucleus accumbens, ventral

tegmental area, globus pallidus, and prefrontal cortex (for

a review, see Bardo, 1998). Together these brain areas
compose the mesolimbic, mesocortical, and mesopallidal
dopamine circuits that were detailed in Chapter 3. The CPP
paradigm has provided evidence implicating each of these

circuits with the reinforcing properties of dopaminergic
drugs.

Mesolimbic Circuitry and Conditioned Place
Preference

The mesolimbic dopamine pathway consists of
dopaminergic cell bodies located in the ventral tegmental
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area and projecting to the nucleus accumbens
Panksepp,

1999; Oades & Halliday,

Microinjecting both direct

indirect

(amphetamine)

(Ikemoto &
1971).

1987; Ungerstedt,

(SKF 38393 and quinpirole)

and

dopamine agonists into the nucleus

accumbens increases the amount of time rats spend in the
drug-paired compartment

Packard,

& Hiroi,

(Carr & White,

1983; 1986; White,

1991). Not surprisingly,

intra-accumbens

microinjections of Di-like and D2-like antagonists

(SCH

23390 and sulpiride) block amphetamine-induced CPP (Hiroi &
White,

1991). Conversely, cocaine-induced CPP is only

blocked when a Di-like receptor antagonist

not a D2-like receptor antagonist

(sulpiride),

microinjected into the nucleus accumbens
Specio, Khroyan,

O'Dell, Fuchs,

& Neisewander,

& Neisewander,

(SCH 23390), and

is

(Baker,

Fuchs,

1998; Baker, Khroyan,

1996). Therefore,

Di-like

receptor stimulation in the nucleus accumbens is more
important for the rewarding properties of cocaine CPP than
is D2-like receptor stimulation (Baker et al.,

1996,

1998).

Mesocortical Circuitry and Conditioned Place
Preference
The mesocortical dopamine pathway is composed of
dopaminergic cell bodies located in the ventral tegmental

area and projecting to the prefrontal cortex (Ikemoto &
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Panksepp,

1999; Oades & Halliday, 1987; Ungerstedt,

1971).

Several lines of evidence suggest that the prefrontal
cortex is associated with the rewarding properties of

cocaine.

First, rats will self-administer cocaine directly

into the prefrontal cortex (Goeders & Smith,

1983,

1986).

Second, destruction of dopamine terminals in the prefrontal

cortex prevents a CPP response to cocaine, but not
amphetamine

(Bardo, 1998; Carr & White,

Nonneman, Neisewander, Landers,

& Ikemoto,

Murphy,

& Bardo,

1986;

Isaac,

1989; McBride,

1999). Taken together, these data

suggest a dissociation between those brain areas mediating
the effects of psychostimulant drugs, with the prefrontal

cortex being more important for cocaine CPP, whereas the

nucleus accumbens is critical for amphetamine CPP (Carr &
White,

1986; Isaac et al.,

1989).

Mesopallidal Circuitry and Conditioned Place
Preference
Emerging research suggests that mesopallidal

circuitry may also be important for the rewarding actions
of psychostimulant drugs

Justice,

(Berridge, 2003; Gong, Neill,

1996; McBride et al.,

1999; Panagis et al.,

&

1997).

This pathway consists of dopamine cell bodies located in
the ventral tegmental area and projecting to the globus
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pallidus

(Klitenick, Deutch, Churchill,

& Kalivas,

1992).

Lesions to the globus pallidus attenuate the reinforcing

effects of cocaine and food reward (Gong et al.,
McAlonan, Robbins,

& Everitt,

1997;

1993). Additionally,

microinjecting amphetamine and cocaine into the globus
pallidus induces CPP (Gong, Neill,

1996). These

& Justice,

data are consistent with electrophysiology studies showing
that pallidal neurons are responsive to systemic cocaine
administration independent of activation of the nucleus
accumbens

(Johnson & Napier,

1996) .

Conditioned Place Preference and
Environmental Toxins
Very few studies have investigated the effects of

environmental toxins on reward processes. Available studies
indicate that exposure to environmental toxins can lead to

changes in the rewarding properties of psychostimulant
drugs. For example, cadmium attenuates place preference

conditioning to low, but not high, doses of cocaine and.

apomorphine
1999).

(Miller,

Palme, Najvar, Caudill,

& Nation,

In addition, perinatal lead exposure attenuates

cocaine- and morphine-induced CPP in adult rats

Nation,

(Miller,

& Bratton, 2000; Valles, Cardon, Heard, Bratton,

&

Nation, 2003). Taken together, these studies indicate that
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environmental toxins are capable of causing long-lasting

alterations in reward function.
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CHAPTER EIGHT

THE EFFECTS OF NEONATAL MANGANESE EXPOSURE ON

IMPULSIVITY, UNLEARNED MOTORIC FUNCTION,
AND REWARD

Summary
Manganese is an essential trace mineral that can

damage the central nervous system. There is increasing
evidence that children may be particularly prone to
manganese neurotoxicity, because immature brains accumulate
manganese more extensively than adult brains and are less

efficient at maintaining homeostatic levels

Ishiwatari,

& Okada,

(Takada,

1999). Therefore, manganese exposure

during development may amplify the risk of neuronal damage

(Cawte,

1985; Lonnerdal,

1994; Weiss,

1999). Of special

concern are infant formulas, because manganese levels in

commercially available infant formulas may be sufficient to
cause lasting behavioral deficits and neurological

dysfunctions that are similar to symptoms observed in ADHD
(Lonnerdal,
DeMet,

Le,

1994; Tran, Chowanadisai, Crinella, Chicz-

& Lonnerdal, 2002; Tran, Chowanadisai, Lonnerdal,

Parker, Chicz-DeMet,

& Crinella, 2002). Thus,

children

fed these formulas may be at risk for lasting brain changes
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that result in long-term behavioral dysfunction

1985; Lonnerdal,

1994; Mergler,

Based on this rationale,

1999; Weiss,

(Cawte,

1999).

I designed a series of

experiments to explore the effects of low-dose manganese

exposure on behaviors that are sensitive to disruption of
the corticostriatal pathway, and the nigrostriatal and

mesocorticolimbic dopaminergic systems. Additionally,

I

investigated the effects of early manganese exposure on

developmental landmarks, sensory and motor development,

and

neurochemical indices of dopamine transporters.

Experiment One
Recent research has found that moderate levels of

manganese, consistent with those found in infant formulas,
are able to produce behavioral and neurochemical
alterations in rats

DeMet,

Le,

(Tran, Chowanadisai, Crinella, Chicz-

& Lonnerdal, 2002; Tran, Chowanadisai, Lonnerdal,

Parker, Chicz-DeMet,

& Crinella, 2002). Specifically,

these reports show that manganese decreases striatal

dopamine levels and impairs performance on tasks that
assess sensory and motor development
Crinella, Chicz-DeMet,

(Tran, Chowanadisai,

& Lonnerdal, 2002; Tran,

Chowanadisai, Lonnerdal, Le,

Parker, Chicz-DeMet,
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&

Crinella, 2002). In these studies, however, ADHD

symptomology, including impulsivity, was not measured.

Therefore, the purpose of this experiment was to
determine whether early manganese exposure affects

impulsivity of adult rats. The DRL paradigm will be used
for two reasons: First, the DRL task is a sensitive measure

of drug-induced changes in impulsivity; and, second,
alterations in dopamine system functioning are known to
affect DRL performance. Thus, if manganese enhances

impulsivity by modulating the dopamine system, the DRL task
should be sensitive to these changes.
Specifically, overall DRL performance was assessed by
examining the total number of bar press responses and

efficiency scores (reinforcement received/total responses)
of saline- and manganese-exposed rats. Impulsivity, timing,
and learning were further examined by analyzing IRT
distributions. I hypothesized that early manganese exposure

would enhance impulsivity of adult rats, as evidenced by
reduced efficiency scores, increased amounts of total

responding, bin 1 responding (responses occurring 0-2 s
after a previous bar press), and burst responding (number

of consecutive responses occurring within 1 s of the
previous bar press). Additionally, manganese-exposed rats
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should have had an increased number of responses in the
time bins preceding the reinforcement bin, indicating a

disruption of temporal processing. I also hypothesized that
manganese-exposed rats should show impairments in

acquisition (learning) of the DRL task as evidenced by

fewer reinforced responses than control rats and a slower
shift of bin responses (i.e., from early time bins to
latter time bins over training days).
Experiment Two

Several lines of evidence suggest that neonatal
manganese exposure can have deleterious behavioral and

neurochemical effects. First, early manganese exposure is
capable of impacting physical maturation, sensory, and
motor development, as well as locomotor activity (Pappas et
al., 1997; Tran, Chowanadisai, Crinella, Chicz-DeMet, &

Lonnerdal, 2002; Torrente et al., 2002). Second, neonatal
manganese exposure causes atypical responding to indirect
dopamine agonists, which is indicative of manganese-induced
neuronal impairments (Leung et al., 1982). These effects

are not uniform, however, so it is not clear if moderate
levels of manganese will induce short- or long-term changes
in motoric development, motor activity, or neuronal
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function. Third, manganese interferes with dopamine
transporter functioning

(Aposhian et al.,

1999).

Therefore, the purpose for this experiment was three

fold. The first purpose was to assess the effects of early
manganese exposure on standard developmental landmarks
(e.g. physical development, motor development,

sensory

function, and activity levels) during the neonatal period.
Balance and coordination was assessed during adulthood. The

second purpose was to assess the effects of early manganese
exposure on basal and cocaine-induced locomotor activity in
preweanling and adult rats. The third purpose was to assess

the effects of early manganese exposure on striatal
dopamine transporters.

I hypothesized that early manganese exposure would
delay the appearance of developmental landmarks,

interfere

with neonatal sensory and motor development, and impair
balance and coordination in adulthood.

I also hypothesized

that manganese-exposed rats would exhibit an attenuated
locomotor response to cocaine challenge.

Finally,

I

hypothesized that manganese would decrease striatal
dopamine transporter binding sites.
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Experiment Three

The rewarding properties of cocaine are mediated by
dopamine release in the nucleus accumbens, prefrontal
and globus pallidus

cortex,

(Bardo,

1998; Hiroi & White,

1990). This is interesting because ADHD has been
hypothesized to result from an immature reward system

(Casey et al.,
al.,

1997; Johansen et al.,

1998; Solanto et al.,

2002; Sagvolden et

1997). There are two reasons to

suspect that manganese may disrupt psychostimulant-induced
reward processes. First, manganese potentiates glutamate-

induced activation of NMDA receptors and NMDA receptors are
implicated in the acquisition of cocaine CPP

Samanin,

1995; Cuesta de Di Zio et al.,

(Cervo &

1995). Second,

manganese accumulates in brain areas associated with the
mesopallidal and mesolimbic reward circuits, including the
globus pallidus, the ventral tegmental area, and the

nucleus accumbens
Neill,

et al.,

& Justice,

(Berridge, 2003; Fell et al.,
1996; 1997; Komaki et al.,

1999; Panagis et al.,

1996; Gong,

1999; McBride

1997).

Currently, most research on neonatal manganese
exposure has focused on alterations of unlearned motor

performance, which is predominantly mediated by the
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nigrostriatal dopamine system. The effect of neonatal
manganese exposure on the mesocorticolimbic dopamine system
has not been fully explored. Therefore, the purpose of this

study is to investigate the effects of neonatal manganese
treatment on drug reward by utilizing a CPP paradigm.

hypothesized that manganese exposure would reduce the
rewarding properties of cocaine, as evidenced by a

decreased amount of time spent in the drug-paired
compartment.
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I

CHAPTER NINE

GENERAL METHODS

Subj ects

Subjects were 208 male and female rats of SpragueDawley descent

(Harlan,

San Diego), born and raised at

California State University, San Bernardino. Rats were

housed in a colony room maintained on a 12:12 light:dark
cycle at 22°-24°C. Litters were culled to 10 on postnatal

day (PD)

1, weaned on PD 24, and group housed until the

start of behavioral testing. Food and water was provided ad
lib. Rats were treated in accordance with the National

Institutes of Health guidelines

("Principles of Laboratory

Animal Care", NIH Publication #85-23)

under a research

protocol approved by the Institutional Animal Care and Use
Committee of California State University,

San Bernardino.

Drugs and Chemicals
Manganese chloride

(Sigma Chemicals, St. Louis) was

dissolved in 10% sucrose solution and administered orally

via micropipette.

(-)-Cocaine hydrochloride

(Sigma) was

dissolved in saline and injected intraperitoneally at a

volume of 5 ml/kg for preweanling rats and 1 ml/kg for
adult rats.
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Statistics

Behavioral data was analyzed using repeated measures
analyses of variance

250,

(ANOVA). Both manganese condition (0,

500, or 750 pig) and sex (male and female) were between

subject variables. Repeated measure variables were day,

trial, or time block depending upon the experiment and

behavioral task. Significant higher order interactions were

further analyzed using one- or two-way ANOVAs.
Neurochemical data were analyzed using nonlinear regression

to determine Bmax and K& values. Group differences were
assessed using one-way (manganese treatment) ANOVAs. All
post hoc comparisons were done using Tukey tests
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(p < .05).

CHAPTER TEN

EXPERIMENT ONE: THE EFFECTS OF NEONATAL MANGANESE
EXPOSURE ON A DIFFERENTIAL REINFORCEMENT

OF LOW RATES OF RESPONSE TASK

. DURING ADULTHOOD

The purpose of Experiment 1 was to assess the effects
of neonatal manganese exposure on the impulsivity of adult

rats by using a DRL-20 task. It was predicted that early
manganese exposure would amplify impulsivity of adult rats,

as evidenced by increased amounts of total responding, bin
1 responding, and burst responding. Additionally, it was

expected that manganese-treated rats would have fewer

reinforced responses and reduced efficiency scores than
control rats.

Methods
Manganese Treatment
A total of 32 rats (n = 8 per group) were used in this

experiment. On PD 1-21, male and female rats were given

daily supplements consisting of 0, 250, 500, or 750 pig

manganese.
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Apparatus

Standard operant chambers (Coulborn Instruments,
Allentown, PA) were used. The chambers were located inside
sound attenuated cubicles and were controlled by an IBM

compatible computer interfaced with Graphic State Notation

software and data collection program. Operant chambers (30 x
30 x 25 cm) included one response lever, a house light, and
a feeder.

Procedures
On PD 83, rats began food restriction (90% of normal
body weight).

On PD 90-94, rats were shaped to bar press

for food reward.

On PD 95, rats began the DRL procedure.

Specifically, on PD 95 and PD 96 rats were placed on a DRL5 schedule of reinforcement where they must withhold a

response for more than 5 s to gain a food reward. Responses

prior to the fixed interval reset the time clock. On PD 97106, rats were advanced to a DRL-10 schedule for 10
consecutive days. Then for the following 30 days, rats were
trained on a DRL-20 schedule in which they received a food

reward after withholding a response for 20 s. Daily
sessions terminated after acquisition of 50 pellets or

until 50 min had elapsed.
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DRL performance was assessed using several different
measures. Total daily bar press responses, total

reinforcements earned, and efficiency scores
(reinforcements received/total responses) were used to

assess overall performance. An analysis of IRTs was used to

measure differences in overall patterns of responding.
Specifically, responses occurring prior to the 20 s

interval were recorded in ten 2-s time bins. Reinforced

responses were recorded in an eleventh time bin. Responses

occurring in the 0-2 s time bin were used as a measure of
impulsivity. Multiple rapid bar press responses occurring

within 1 s of each other were grouped and termed burst
responses.
Statistics

Total responses, efficiency scores, reinforcements
received, bin 1 responses, and burst responses were

analyzed using separate 4 x 2 x 10
sex x time block)

(manganese condition x

repeated measures ANOVAs. The manganese

independent variable consisted of four levels of manganese

pretreatment

(0, 250,

500 or 1000 |ig manganese per day); the

sex independent variable consisted of male and female rats;

and the repeated measure was over 30 days of DRL
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performance divided into 10 three-day time blocks.

comparisons were done using Tukey tests

Post hoc

(p < .05).

Results

Differential Reinforcement of Low Rates of
Responding: 5 - Second Delay
Early manganese exposure did not impact acquisition of
bar press shaping on an FR 1 schedule of reinforcement.

During the subsequent two days of DRL 5 training, manganese
interacted with sex to affect total number of bar press
[manganese x sex interaction,

responses

F(3,47)=3.09,

P <

0.05]. However, post hoc comparisons using Tukey tests did

not reveal any significant differences between groups.
Additionally, when males and females were analyzed

separately, manganese did not affect total bar press
responses.

Differential Reinforcement of Low Rates of
Responding: 10 - Second Delay
During the 10 days of DRL 10 training, manganese
exposure did not alter performance on any behavioral

measures

(efficiency scores, total number of responses, or

burst responding). Additionally, manganese-induced effects

were not apparent on an analysis of inter trial response
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Figure 5. Analysis of intertrial response time (IRT) bin
distributions of male (upper graph) and female (lower
graph) rats (n = 6-8). Time bins (2 s) are totaled over the
10-day testing session. Rats were pretreated with manganese
from PD 1-21.
aSignificant difference between manganese-treated rats and
vehicle controls (R < 0.05).
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times for male or female rats

rats

(Fig.

5). In general, male

(329.15 ± 24.13) bar pressed significantly more than

female rats

(245.00 ± 13.79)

[sex main effect

F(l,47)=10.43, P < 0.05], with this effect reaching

significance on days 1-4
F(9,423)=2.86,

[sex x day interaction,

P < 0.05]. Additionally, male rats

(65.71 ±

7.11) made more 1 s burst responses than female rats
± 3.59)

on the DRL 10 schedule of reinforcement

effect,

F(l,47)=8.77, P< 0.05].

(42.75

[sex main

Differential Reinforcement of Low Rates of
Responding: 20 - Second Delay
Over 30 consecutive days of DRL 20 training,
efficiency scores did not differ according to manganese

exposure or sex. Manganese exposure also did not affect
total number of bar press responses. Overall, male rats

(234.97 ± 20.94) had more bar press responses than female
rats

(183.09 ± 11.78)

[sex main effect, F(l,53)=4.915,

P <

0.05]. To further evaluate differences between controls and

manganese-exposed rats, interaction comparisons were
performed on total number of bar press responses.

combined across manganese treatments

(250,

Data were

500, and 750 pg)

and harmonic means were used to adjust for uneven sample
size. The total number of bar press responses of manganese-
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700

Blocks of Three Days

Figure 6. Mean total bar press responses (± S.E.M.) of
adult male and female rats (n = 6-8) tested on a
differential reinforcement (DRL) 20 s schedule for 30
consecutive days. Rats were treated with manganese from PD
1-21. Inset shows the average total bar press responses.
aSignificantly different from manganese-treated rats
(P < 0.05).
bSignificantly different from male rats (P < 0.05).
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exposed rats varied according to sex (Fig.

6, inset)

[manganese x sex interaction, F( 9, 459)=2.98,

P < 0.05]. For

male rats, manganese caused a significant reduction in
total number of bar press responses across the first 12

days

(time blocks 1-4)

graph)

of DRL 20 testing

(Fig.

[manganese x time block interaction,

< 0.05; and Tukey tests,

6, top

F( 9,216)=2.75,

P < 0.05]. For female rats,

manganese did not alter total bar press responses

(Fig.

6,

bottom graph).
Responses occurring within 1 s of each other were

grouped and termed burst responses. Male rats

(40.41 ±

7.08) made more 1 s burst responses than female rats
± 3.67)

[sex main effect,

F(l,47)=6.23,

(22.40

P < 0.05]. Burst

responses varied by manganese exposure and sex over the 30
days of DRL 20 training (Fig. 7)

interaction, F(27,423)=1.95,

[manganese x sex x day

P < 0.05].

Interaction

comparisons were conducted by combining manganese exposure

groups. The number of 1 s burst responses varied for

manganese-exposed rats according to sex (Fig.

7,

inset)

[manganese x sex interaction, F( 1,51)=7.32, P < 0.05].
Comparisons between manganese exposed groups
750 pg)

(250,

500,

and controls showed that male rats exposed to
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or

P

Figure 7. Mean (± S.E.M.) 1 s burst responses made by adult
male and female rats (n = 6-8) tested on a differential
reinforcement (DRL) 20 s schedule for 30 consecutive days.
Rats were treated with manganese from PD 1-21. Inset shows
the average total number of 1 s burst responses.
aSignificantly different from manganese-treated rats
(P < 0.05) .
bSignificantly different from male rats (P < 0.05).
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manganese committed fewer 1 s burst responses than controls

during time blocks 1-6

(Fig. 7, top graph)

P < 0.05; and Tukey

time block interaction, F(9, 216)=4.32,

tests,

[manganese x

P < 0.05]. The 1 s burst responses of female

manganese-exposed rats did not differ from vehicle-treated
rats

(Fig. 7, bottom graph).
An analysis of intertrial response times showed that

differences in the bin distribution of manganese-treated
rats varied according to sex throughout the 30 days of DRL

testing

(Fig. 8)

F(30,470)=2.59,

[manganese x sex

x response bin,

P < 0.05]. For male rats, manganese reduced

bin 1 responses during time blocks 1-7

[manganese x time block interaction,
0.05; and Tukey tests,

(Fig.

9)

F(27,198)=5.48,

F<0.05]. In contrast,

P <

female rats

exposed to manganese pressed the bar more than controls

(Fig. 10, upper graph)

[manganese x time block interaction,

F(27,225)=1.67, P < 0.05; and Tukey tests,
Specifically,

female rats pretreated with 500 pg manganese

had more bin 7 responses on days 4 - 6

2); whereas,

P < 0.05].

(i.e., time block

female rats pretreated with 750 pg manganese

had more bin 7 responses than vehicle-treated rats on days

7-15

(i.e., time blocks 3-5)
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(Fig. 10, upper graph).

6000-

Figure 8. Analysis of intertrial response time (IRT)
bin distributions of male (upper graph) and female
(lower graph) rats (n = 6-8). Time bins (2 s) are
totaled over the 30-day testing session. Rats were
pretreated neonatally with manganese from PD 1-21.
aSignificant difference between manganese-treated rats
and vehicle controls (P < 0.05).
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Figure 9. Mean bar (± S.E.M.) press responses occurring in
the 0-2 s time bin (i.e., time bin 1) for male rats (n = 6
8) during the 30 days of testing divided into ten 3-day
time blocks. Rats were pretreated neonatally with manganes
from PD 1-21.
aSignificantly different from manganese-treated rats
(P < 0.05).
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Figure 10. Mean (± S.E.M.) number of bar press responses of
female rats (n = 7-8) occurring in bin 7 (upper graph) and
bin 11 (lower graph). The 30 days of testing are divided
into ten 3-day blocks. Rats were pretreated with manganese
(0, 250, 500, or 750 jxg) on PD 1-21.
aSignificantly different from vehicle-treated rats
(P < 0.05).
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Manganese exposure also affected the number of reinforced
responses of female rats in bin 11

interaction, F(27,225)=1.56,

[manganese x time block

P < 0.05; and Tukey tests,

P <

0.05]. Specifically, vehicle-exposed rats received more

reinforcements on days 10 - 12 than rats pretreated with 50
lag manganese (i.e., time block 4)

(Fig.

10,

lower graph) .

Discussion: Experiment One
Accurate performance on the DRL task requires precise

estimation of time duration and the ability to inhibit a
response, consequently this task is commonly considered a

sensitive measure of impulsivity (Monterosso & Ainslie,

1999; Wiley et al., 2000). In addition, the DRL task is
sensitive to alterations of the dopamine neurotransmitter
system, therefore this task can be used to assess the

effects of environmental neurotoxins on dopamine neurons.
In the current study, neonatal exposure to manganese was

evaluated on DRL 5, 10, and 20 schedules of reinforcement.
It was originally hypothesized that manganese treatment

would increase the impulsive responding of both male and
female rats. However, the pattern of results reflects an

overall reduction of responding in male rats and a subtle
response increase in female rats.
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Manganese-exposed rats were shaped over four days to

press a lever for food reward and there were no differences
in the ability of rats to acquire the operant response.

During DRL training, female rats made fewer non-reinforced
responses than male rats on the DRL 10 and 20 tasks. These

findings are consistent with previous studies showing
sexually dimorphic response rates on the DRL task, (van

Hest, van Haaren,

& van de Poll,

1987). Moreover, the

present experiment demonstrated that neonatal manganese
exposure impacted male and female rats differently.
Specifically, manganese reduced total bar press responding,

burst responding, and bin 1 responses of adult male rats.
Female rats did not differ on these measures; however,

an

analysis of the IRT bin distribution for female rats showed
that manganese exposure caused increased responses in time
bin 7 and decreased responses in time bin 11.
In the current study, manganese-exposed male rats had
fewer total bar press responses and 1 s burst responses

relative to vehicle-exposed rats. An analysis of the IRT
bin distribution demonstrated that the decrease in bar

press responding for male rats was predominately caused by
reduced responses in time bin 1. Responses occurring in the

first time bin are indicitive of the ability to delay or
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inhibit a voluntary behavior (Monterosso & Ainslie,
Wiley, Compton,

1999;

& Gorden, 2000). Taken together, it appears

as if neonatal manganese treatment caused a decrease in
impulsivity. In fact, this pattern of manganese-exposed

effects is reminiscent of the behavioral response patterns

induced by dopamine antagonist drugs. Dopamine antagonists
slow down DRL performance, thus decreasing response rates
and causing longer IRTs

al., 2001; Paule et al.,
Shaughnessy,

(Britton & Koob,

1989; Compton et

1999; Seiden, Dahms,

&

1985; Wiley et al., 2000) .

Based on these considerations,

it is probable that

neonatal manganese treatment attenuates dopamine
transmission in a way that depresses motor,

reward, or

attentional functioning on the DRL task. For instance, the

reduced bar press responding exhibited by manganese-treated
male rats could result from manganese-induced alterations
of the nigrostriatal dopamine pathway. Since manganese

toxicity is commonly associated with extrapyramidal motor 1
impairments, the generalized slowing of responses observed
in manganese-exposed rats could be indicative of subtle

long-term deficits in motoric ability. Similar to the

effects of dopamine antagonists, manganese-exposed rats may
have taken longer to terminate individual responses,
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thereby reducing the number of response opportunities
available during a testing session (Ettenberg,

1989) .

Decreased responses consisted primarily of rapidly executed
burst responses and responses with short IRTs

(i.e.,

1 s

burst and bin 1 responses), which further suggests that
manganese may cause subtle motor difficulties. Consistent

with this idea, manganese-exposed (5 and 10 mg/kg, i.p.)
adult cebus monkeys had multiple failed attempts to

complete a lever moving task on a variable ratio schedule
of reinforcement

(Newland & Weiss,

1992). Moreover,

manganese exposure caused these monkeys to increase the
length of IRT's, to decrease overall responses, and to
eliminate burst responses

(Newland & Weiss,

1992). Thus,

manganese-induced motor impairment is a probable
explanation for the reduced responses observed on the DRL
20 task.

Alternately, manganese may depress reward system

functioning in male rats, hence the decreased bar press

responding may reflect a lack of motivation for the food
reinforcer. Because food reward is mediated,

in part, by

mesolimbic dopamine transmission (Fell et al.,
Neill,

& Justice,

1996; 1997; Zhang, Balmadrid,

1996; Gong,

& Kelly,

2003), accumulation of manganese in the mesolimbic pathway
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may depress dopaminergic mediation of food reward. More
specifically, manganese- and vehicle-exposed rats performed

similarly on DRL 5 and DRL 10 tasks; however the increased
difficulty of the DRL 20 task may have revealed a reduction
in the saliency of food reward. Thus, manganese-exposed

rats may be less inclined to bar press on a more difficult

schedule of reinforcement.

Another possible explanation for the manganese-induced
reduction in bar press responses is that manganese could

have adversely affected attentional processes of male rats

(i.e., the animals were easily distracted). For example,
mesocortical dopamine transmission is important for

modulating associative processes involved in decision

making, attentional control, and working memory, processes
collectively referred to as "executive functions"

(Barkley,

2003; Sullivan & Brake, 2003). Mesocortical dopamine is
essential for an organism to focus more precisely on
specific stimuli controlling behavior at a given time

(Robbins, 2000; Sullivan & Brake, 2003). Since DRL

performance is dependent on both cortical and striatal

dopamine function, reductions in mesocortical dopamine
could adversely affect DRL performance
Sokolowski & Salamone,

1994).
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(Neil,

1967;

In contrast to male rats, manganese-exposed female
rats did not show a decrease in rapidly executed burst

responses, but instead showed subtle response increases in

time bin 7. The increased responses observed prior to the
fixed interval can be explained in two ways. First,

manganese may have impaired the timing ability of female
rats. However, this is unlikely since the number of

responses in those time bins immediately prior to
reinforcement (i.e., bins 9 and 10) did not vary.
Alternately, manganese may have disrupted the ability of

female rats to adapt to the new response requirements
(i.e., a 20 s withholding period), because prior

performance on a DRL 10 schedule may have interfered with
later performance. Specifically, manganese-exposed female

rats were unable to transfer learning from a DRL 10

scheduale to a DRL 20 scheduale. For example, manganese
caused a dose-dependant increase in bar press responses

sequentially surrounding the 10 s delay (i.e., bins 5-8),
with the manganese effect reaching statistical significance

on time bin 7. The transient nature of this effect
(occurring on days 2 - 15) is suggestive of a delayed
adaptation to the new response contingency, because

performance was consistent with controls during the final
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testing sessions. The decreased number of reinforcements

earned by manganese-exposed females supports this idea,
because increased responding during the 20 s delay would
lead to a decline in the number of opportunities to earn

reinforcement. A similar response pattern was observed in

female rats exposed to polychlorinated biphenyls
(Holene et al.,

1999). Specifically,

(PCB)

PCB-treated females

had difficulty adapting from a variable interval/extinction

paradigm to a DRL 14 task. Holene and colleagues

(1999)

suggested that the PCB-exposed females exhibited a
temporary delay in acquisition of the new reinforcement

schedule.

When considered together, the differential responding
of male and female manganese-exposed rats supports previous

research demonstrating that developmental neurotoxicants

are capable of producing sex-dependant effects
al., 2002; Holene et al.,

(Hojo et

1999; Weiss, 2002). Because the

developing endocrine system is vulnerable to exogenous

compounds, alterations in gonadal hormones may contribute
to the disparities observed in male and female rats

(Weiss,

2002). At this point, it is important to note that male

rats are particularly sensitive to neurotoxicants that
damage the nigrostriatal dopamine system (Miller, Ali,
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O'Callaghan,

& Laws, 1998). This is largely attributed to

the neuroprotective effects of estrogen (Dluzen,

Miller et al.,

2000;

1998). Although preweanling females have

higher concentrations of serum estradiol than males
Govindarajulu,

& Aruldhas,

(Banu,

2002), it is uncertain whether

these levels are sufficient to produce neuroprotective

effects during manganese exposure. Conversely, testosterone

is known to affect performance on operant tasks
Haaren, van Hest, & Heinsbroek,
& van de Poll,

(van

1990; van Hest, van Haaren,

1989), so it is possible that the

differential responding of male and female rats may have
been due to the presence of testosterone rather than the

neuroprotective effects of estrogen.
In conclusion, early manganese exposure impacted the
DRL performance of adult rats. Interestingly, many of these

effects varied according to sex. These manganese-induced

effects may involve several different dopamine-mediated
systems: motor, reward, attention, and/or learning.

Nevertheless, the present results indicate that neonatal
manganese exposure has long-term behavioral consequences

when performance is assessed on a DRL task.
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CHAPTER ELEVEN

EXPERIMENT TWO: THE EFFECTS OF NEONATAL MANGANESE
EXPOSURE ON UNLEARNED BEHAVIORS AND

DOPAMINE TRANSPORTERS

The purpose of Experiment 2 was threefold. The first
purpose was to examine the effects of early manganese
exposure on general motoric ability of neonatal and adult

rats. It was expected that neonatal manganese treatment
would cause impairments in neonatal sensory and motor
development, and impair balance and coordination in

adulthood. The second purpose was to investigate the

effects of neonatal manganese on basal and cocaine-induced
locomotor activity of preweanling and adult rats.

It was

predicted that manganese-exposed rats would exhibit an

attenuated locomotor response to cocaine challenge. The

final purpose was to assess the effects of early manganese
exposure on dopamine transporter binding sites in the
striatum.

It was expected that early manganese exposure

would decrease the number of striatal dopamine

transporters.

105

Methods
Manganese Treatment
A total of 72 rats

experiment.

(n = 8 per group) were used in this

On PD 1-21, rats were given supplements

consisting of 0, 250, or 750 pg manganese dissolved in 25 pi
of 10% sucrose solution.

Apparatus

Locomotor activity was measured using commercially
available activity chambers

Allentown,

(Coulbourn Instruments,

PA). For neonatal and preweanling animals the

chambers measured 25.5 x 25.5 x 41 cm and for adult animals
the chambers measured 41 x 41 x 41 cm. Both sized chambers

consisted of acrylic walls, a plastic floor,

top.

and an open

Each chamber utilized an X-Y photobeam array with 16

photocells and detectors to determine the total distance
traveled (a measure of horizontal locomotor activity).
Olfactory orientation was measured in a Plexiglas

enclosed runway (12 x 28 x 12 cm) with soiled home bedding
at one end and clean bedding at the other end. Negative

geotaxis was tested on a 25° Plexiglas inclined plane. The

surface of the inclined plane was covered with sandpaper.

Adult balance and coordination was evaluated on an elevated
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balance beam (49 x 22 x 150 cm)

at a 15° incline. A darkened

goal box was placed at the elevated end of the beam.

For

male rats the beam width was 1.9 cm and the beam width for

females was 1.3 cm.

Procedures

Developmental Landmarks. Pups were fed manganese daily
between PD 1-21 and evaluated daily for developmental
landmarks

(i.e., eye opening, pina detachment, and incisor

eruption). Specifically,

eye opening was recorded when both

eyes lids were completely separated. Pina detachment was

recorded when the tip of the ear is separated from the
head.

Incisor eruption was recorded on the first appearance

of upper incisors. Body weights were recorded on alternate

days.

Neonatal Sensory and Motor Development.

Negative

geotaxis was used to measure the development of motor

ability and motor reflex. On PD 8,

PD 10, and PD 12

neonatal pups were placed head down on the 25° inclined

plane and latency to rotate 180° on the inclined plane was

measured during a 120 s testing session.

If the rat fell,

crawled off the plane, or braced (no movement), the rat
failed the task and a maximum time of 120 s was assigned.
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Olfactory discrimination was assessed as a measure of

sensory development. On PD 9,

PD 11, and PD 13 all pups

were tested individually for olfactory discrimination of
their home cage bedding. Specifically,

5-day old soiled

bedding from their home cage was placed at one end of the

runway while fresh bedding was placed at the other end.
Each pup was placed on a center line with the head facing

the Plexiglas wall. Latency to reach the home bedding was

recorded.

If the pup did not complete the trial in 120 s or

if the pup reached the clean bedding, the pup was

considered to have failed the task and a maximum time of

120 s was assigned.
Locomotor activity was used to as a measure of motor

development. On PD 10, PD 12, and PD 14 motor activity for

each pup was recorded for 1 min in the activity chambers.
Total distance traveled and total number of movements per

episode was recorded.

Adult Balance and Coordination. On PD 90, manganeseexposed adult rats were tested for balance and coordination

using a balance beam task. Each rat was given three trials.
On trial 1, rats were placed in the goal box for 30 s. Then
an experimenter blind to the treatment condition placed the

rat on the low end of the balance beam. On trials 2 and 3,

108

centrifuged at 20,000 x g at 4° C for 20 min. The pellet was

resuspended in ice-cold buffer and centrifuged again at
20,000 x g at 4° C for 20 min. The final pellet was

suspended in 12 vol of buffer. Protein concentrations for
the final pellet were determined using the Bio-Rad Protein

Assay with BSA as the standard.
Saturation binding assays were conducted in duplicate.
Each assay tube contained 430 pg of buffer, varying levels
of [3H]GBR 12935

(12 final concentrations,

tissue suspensions

0.1 - 37 nM), and

(50 pg/protein). Non-specific binding

was determined in the presence of 10 pg GBR 12909 which

selectively inhibits dopamine transporter function. The

incubation period lasted 90 min at 4° C. Incubation was
terminated by vacuum filtration (Brandell)

filter fibers

over glass

(Brandell) previously soaked in 0.1%

polyethylenimine.

Filters were washed three times with ice-

cold Krebs-HEPES buffer and radioactivity was measured by
liquid scintillation spectrometry.

Statistics

Behavioral Data. Separate between subject

(manganese

condition x sex) ANOVAs were used to analyze eye opening,
pina detachment, and incisor eruption. Body weights
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throughout the neonatal period were analyzed using 3 x 2 x
11

(manganese condition x sex x day)

repeated measures

ANOVA. Negative geotaxis, olfactory orientation,

and

neonatal locomotor activity were analyzed using 3x2x3

(manganese condition x sex x day)

repeated measures ANOVAs.

To control for litter effects, means were calculated on

each dependant measure for manganese treatment groups

250, or 750 pg manganese)

(0,

for both male and female rat

pups. Thus, only one score was used for each level of
manganese pretreatment per litter per sex.

On the balance

beam task, time to travel to the goal box,

freezes and foot

slips were analyzed with separate 3x2x3

(manganese

condition x sex x trial) repeated measures ANOVAs.

For preweanling rats, saline and cocaine-induced
locomotor activity was analyzed using a3x3x2xl2

(manganese condition x cocaine dose x sex x time block)
repeated measures ANOVA. Pre-injection body weights were
analyzed using a 3 x 2

(manganese condition x sex) ANOVA.

For adult rats, locomotor activity was analyzed using a 3 x

3 x 2 x 12 x 5

(manganese condition x cocaine dose x sex x
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time block x days) ANOVA. All post hoc comparisons were done
using Tukey tests

(p < .05).

Neurochemical Data. Dopamine transporter binding sites
(Bmax)

and affinity (Fd) were determined using nonlinear

regression with Prism (GraphPad Software, San Diego, CA).
Bmax and Kd data from homogenate ligand-binding assays were

analyzed using separate randomized block (manganese

condition) between-subject ANOVAs. Each of the 7 assays
were treated as separate blocks. This statistical procedure

allows for the variance between assays to be partitioned
out of the error term. All post hoc comparisons were done

using Tukey tests

(p < .05).

Results

Neonatal Assessments
Manganese exposure caused a significant reduction in

body weights

[manganese main effect,

F(2,90)=3.93,

P <

0.05]. This effect was only evident during the later part
of the exposure phase, because rats exposed to 750 pg

manganese weighed less than rats exposed to vehicle or 250
pg manganese on PD 15-21

interaction,
pups

(Fig.

F( 20,900)=1.88,

11)

[manganese x day

P < 0.05]. Overall, male

(21.32 g ± .28) weighed more than female pups
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60

Postnatal Day
Figure 11. Mean (± S.E.M.) body weight data of preweanling
rats (n = 31-33) treated from PD 1-21 with daily oral
supplements of manganese (0, 250, or 750 pg).
aSignificant difference between rats exposed to 250 pg or
750 pg manganese (P < 0.05).
^Significant difference between rats exposed to vehicle
or 750 pg manganese (P < 0.05).

113

(20.60 g ± .26)

regardless of manganese condition

[sex

main effect, F(2,90) =4.15, P < 0.05].
Manganese exposure did not alter developmental

landmarks including: pina detachment, incisor

eruption, or eye opening (Table 1). Manganese exposure
did affect performance on the negative geotaxis task,

because rats exposed to manganese exhibited an
increased latency to turn 180° on a 25° inclined plane
(Table 2)
0.05].

[manganese main effect,

F(2,44)=4.45,

P <

Performance on the olfactory discrimination

task and motor activity task was not affected by
manganese exposure

(Table 3).

Acute Cocaine Challenge: Preweanling Rats
On PD 23, body weights did not vary according to

manganese treatment or sex (Table 4). Manganese exposure

did not alter basal or cocaine-induced locomotor activity
of preweanling rats

(Fig. 12); however, rats challenged

with cocaine on PD 23

(10 and 20 mg/kg)

showed enhanced

distance traveled scores when compared to vehicle-treated
rats

(Fig. 12)

[cocaine main effect,

0.05]
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F(2,134)=159.25, P <

Table 1. Mean (± S.E.M.) Age (postnatal day,
Expression of Developmental Landmarks.

PD)

at

Developmental Landmarks

Treatment

Eye
Opening

Pina
Detachment

Incisor
Eruption

Vehicle

3.52 ± 0.16

9.30 + 0.22

15.60 ± 0.17

250 pg
Manganese
750 pg
Manganese

3.60 ± 0.17

9.19 ± 0.11

15.58 ± 0.13

3.57 ± 0.16

9.25 ± 0.18

15.53 ± 0.10

Note:

Rats were exposed to vehicle or manganese on PD 1-21.
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Table 2. Mean (± S.E.M.) Latencies (s) of Rat Pups to
Complete the Negative Geotaxis Task.
Negative Geotaxis

Treatment

PD 8

PD 10

PD 12

Vehicle

27.15 ± 6.78

16.90 ± 4.16

12.10 ± 1.55

18.72 ± 2.91

250 pg
Manganese

19.16 ± 3.87

15.80 + 3.57

12.05 ± 2.45

15.67 ± 2.04

7 50 pg
Manganese

28.86 ± 6.08

29.11 ± 8.10

22.53 ± 5.59

a26.83 ± 2.91

Average

Note: Rats were exposed to vehicle or manganese on PD 1-21.
aSignificantly different from rats exposed to vehicle or 250
pg (P < 0.05).
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Table 3. Mean (± S.E.M.) Latencies (s) and Distance
Traveled Scores (cm) of Rat Pups Tested on the OlfactoryOrientation and Motor Activity Tasks.

Treatment

Sensory and Motor Development

Olfactory Orientation

Motor Activity

Vehicle

34.32 ± 3.11

288.88 ± 5.13

250 pg Manganese

36.11 ± 3.12

283.97 ± 5.55

750 pg Manganese

33.78 ± 3.12

280.72 ± 6.99

Note: Rats were exposed to vehicle or manganese on PD 1-21.
Olfactory orientation was measured on PD 9, 11, and 13,
while distance traveled was measured on PD 10, 12, and 14.
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Table 4. Mean (± S.E.M.) Body Weights
Female Rats on PD 23 and 91.

0 pg Mn

Treatment

(g)

250 pg Mn

of Male and

750 pg Mn

PD 23
Males

59.56

±2.02

58.09

±1.92

57.01

±2.71

57.94

± 1.69

57.35

±1.49

52.93

±1.81

Females

PD 91

Males

382.37

± 4.64 a

390.45

± 4.20 a

389.64

± 3.99 a

Females

237.75

+ 2.38

238.95

±3.09

237.96

±2.83

Note:

Rats; were exposed to vehicle or manganese on PD 1-21.

aSignificantly different from female rats
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(P < 0.05).
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Figure 12. Mean (± S.E.M.) distance traveled scores of rats
(n = 16-17) challenged with cocaine (10 or 20 mg/kg) or
saline on PD 23. Rats were injected after a 5 min
habituation period and immediately placed into the chamber
where locomotor activity was assessed for 60 min. Rats had
been exposed to vehicle or manganese (250, or 750 pg) on PD
1-21.
aSignificantly different from rats given a challenge
injection of 0 mg/kg cocaine (P < 0.05).
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Adult Balance and Coordination
When tested on the balance beam,

latency to reach the

goal box did not differ in male rats exposed to vehicle
(48.48 s ± 9.42), 250 pg

(47.70 s ± 10.75)

s ± 5.64) manganese. Similarly,
vehicle

or 750 pg

(46.76

female rats exposed to

(48.88 s ± 9.85), 250 pg (55.75 s ± 10.52)

or 750

pg (60.58 s ± 10.68) manganese did not differ on the

balance beam.
Acute Cocaine Challenge: Adult Rats
On PD 91, body weights of vehicle- and manganese-

exposed rats did not differ, however male rats weighed
significantly more than female rats
effect,

F(l,140)=2554.99,

(Table 4)

[sex main

P < 0.05]. Distance traveled

scores of manganese-exposed rats did not interact with

cocaine and sex (Fig.

13)

[manganese x cocaine x sex

interaction, F(2,128)=2.37, P = 0.056]; however, the

cocaine variable interacted with sex to affect behavior

[cocaine x sex interaction,

F(2,128)=14.81,

P < 0.05]. More

specifically, an acute challenge injection of cocaine

caused a dose-dependant increase in the distance

traveledscores of male and female rats, with both doses of
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5-Min Time Blocks

5-Min Time Blocks

Figure 13. Mean (± S.E.M.) distance traveled scores of rats
(n = 8-9) challenged with cocaine (0, 10 or 20 mg/kg) on PD
91. Rats were injected after a 5 min habituation period and
immediately placed into the chamber where locomotor
activity was assessed for 60 min. Rats had been exposed to
manganese (250 or 750 jig) or vehicle on PD 1-21.
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cocaine causing significantly greater distance

traveled scores in female rats than male rats

(Fig.

14) .
Cocaine also interacted with the manganese

variable to affect distance traveled scores
manganese interaction,

F(4,128)=3.59,

[cocaine x

P < 0.05]. When

challenged with saline, distance traveled scores of

vehicle- and manganese-exposed rats did not differ
(Fig.

15, upper graph). In contrast, when challenged

with 10 mg/kg cocaine, rats previously exposed to 250
pg manganese had smaller distance traveled scores than

vehicle controls during time blocks 2 and 3

middle graph)

(Fig 15,

[manganese x time block interaction,

F( 14,322)=2.30,

P < 0.05]. When challenged with 20

mg/kg cocaine, rats exposed to 750 pg manganese had
smaller distance traveled scores than rats exposed to

vehicle or 250 pg manganese [manganese main effect,
F(2,

43)=3.44,

P < 0.05]

(Fig 15,

lower graph).

Additionally, cocaine caused a dose-dependent increase
in the distance traveled scores of rats exposed to

vehicle or 250 pg manganese, but not for rats exposed
to 750 pg manganese

(Fig. 16).
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Adult Rats

Cocaine (mg/kg)

Figure 14. Mean (± S.E.M) distance traveled scores of rats
(n = 24-25) challenged with cocaine (0, 10 or 20 mg/kg) or
saline on PD 91. Rats were injected after a 5 min
habituation period and immediately placed into the chamber
where locomotor activity was assessed for 60 min. Rats had
been given daily oral supplements of manganese (250 or 750
pg) or vehicle on PD 1-21.
aSignificantly different from same-sexed rats given a
challenge injection of 0 mg/kg cocaine (P < 0.05).
bSignificantly different from male rats given the identical
dose of cocaine (P < 0.05).
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Figure 15. Mean (± S.E.M) distance traveled scores of male
and female rats (n = 16-17) challenged with cocaine (0, 10,
or 20 mg/kg) on PD 91. Rats were injected after a 5 min
habituation period and immediately placed into the chamber
where locomotor activity was assessed for 60 min. Rats had
been exposed to manganese (250 or 750 pg) or vehicle on PD
1-21.
aSignificantly different from rats pretreated with 0 pg
manganese and challenged with the identical dose of
cocaine (P < 0.05).
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Figure 16. Meanj (± S.E.M) distance traveled scores of rats
(n = 16-17) challenged with cocaine (0, 10 or 20 mg/kg) on
PD 91. Rats were injected after a 5 min habituation period
and immediately|placed into the chamber where locomotor
activity was assessed for 60 min. Rats had been exposed to
manganese (250 or 750 pg) or vehicle on PD 1-21.
aSignificantly different from rats exposed to the same dose
of manganese ana given a challenge injection of 0 mg/kg
cocaine (B < 0.p5).
bSignificantly different from rats exposed to the same dose
of manganese and given a challenge injection of 10 mg/kg
cocaine (B < 0.05).
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Dopamine Transporter Binding Sites

Neonatal manganese exposure caused a decrease in
!
i
striatal dopamine transporter binding sites that persisted
into adulthood [manganese main effect,

0.05]

(Fig. 17).j Specifically,

F(2,

16)=3.72,

P <

rats exposed to 750 pg

manganese had smaller B^x values than control rats

(Fig.

18). Manganese did not significantly affect Ka values,

although there was a trend for manganese to cause a dosedependant decline in Fd (Table 5) .

Discussion: Experiment Two

Evidence fiom other studies has suggested that

exposure to manganese can result in behavioral and
II
neurological changes to the developing nervous system.
However, it is not clear if chronic exposure to low or

moderate doses of manganese during the neonatal period is

capable of inducing long-term changes in behavior. Thus,
one purpose of this experiment was to assess the effects of

manganese on standard measures of physical,

sensory, and

motor development during the neonatal period and then to

I
assess balance and coordination in adulthood. Exposure to

environmental tjoxins can alter behavioral responses to
dopaminergic drugs. Therefore, another purpose of this
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Figure 17. Representative [3H]GBR 12935 saturation curve of
dopamine transporter binding in the striatum of male rats
exposed to manganese (250 or 750 pg) or vehicle from PD 121.

i
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Figure 18. Mean (± S.E.M.) Bmax values for
binding in the striatum of rats (n = 5-7)
manganese (250 or 750 pg) or vehicle on PD
aSignificantly different from rats exposed

0.05).
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[JH]GBR 12935
exposed to
1-21.
to vehicle (P <

Table 5. Mean (± S.E.M.) Bmax and Kd Values for [JH]GBR 12935
Binding in the S-triatum of Rats Exposed to Manganese (250
or 750 pg) or Vehicle on PD 1-21.
Bmax (fmol/mg protein)

■d

(nM)

Vehicle

932.15 ± 185.47

44.07 + 12.47

250 pg Manganese

743.37 ± 105.74

31.78 +

7.70

750 pg Manganese

355.92 + 100.86a

16.34 +

7.01

aSignificantly d ifferent from rats exposed to vehicle
0.05) .

i
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(P <

experiment was to determine if early manganese exposure was

capable of alterjing dopamine-mediated locomotor activity in
preweanling and {adult rats. We found that manganese did not

affect the expression of developmental landmarks, but did
reduce the norma 1 pattern of weight gain during the last
week of manganes'e exposure. Manganese (750 pg) also

impacted the development of motor coordination (i.e.,
negative geotaxi s) at PD 8 - 12 without concomitant effects

on olfactory ori'entation or motor activity. Additionally,
when tested on PD 23, basal and cocaine-induced motor
activity was not affected by manganese.

On PD 91, neonatal manganese exposure did not affect

basal motor activity of adult rats. However, when injected
with cocaine, manganese-exposed rats had smaller distance
traveled scores 'than controls. Additionally, cocaine caused

a dose-dependent increase in the locomotor activity of both
male and female jrats, with female rats exhibiting more
robust cocaine-induced locomotor activity than male rats.

In control rats,| manganese also reduced the density of
dopamine transporters in the striatum (Bmax) > while causing
a non-significant decline in affinity (Fd) .
Although exlposing mice to manganese during late
gestation has been reported to cause a delay in the
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appearance of developmental landmarks

(e.g., pina

detachment, incisor eruption, eye opening)

(Torrente et

al., 2002), such changes were not evident in the current

study. The most obvious explanation is the method of

manganese exposure, because during gestation the fetus is
directly exposed to manganese crossing the placenta via

active transport

(Krachler, Rossipal,

& Micetic-Turk,

1999). Although fetal rats are more susceptible to the

neurotoxic effects of manganese than are neonatal and
preweanling rats, the current study demonstrates that

neonatal manganese exposure is capable of causing short

term changes in the dopamine system that are apparent
during the preweanling period. Manganese delayed the

ability of rat pups

(PD 8,

10, and 12)

to coordinate the

movements required to turn 180° on a 25° inclined plane.

Proper execution of this task typically reaches asymptotic
levels by PD 8 and is dependant upon the vestibular system
(Adams et al.,

1985). Dopamine is involved in modulating

the vestibular system either by directly stimulating
vestibular neurons or by modulating GABAergic neurons in
this area

(Vibert, Serafin, Crambes, Vidal,

& Muhlethaler,

1995). Manganese-induced changes in balance and

coordination were restricted to the preweanling period,
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because vehicle- and manganese-exposed adult rats performed
similarly on the balance beam task. In addition to

measuring negative geotaxis, vehicle- and manganese-exposed
rats were tested on olfactory discrimination and motor
movement tasks. Manganese did not affect performance on

either of these tasks. This pattern of results was
surprising, because both olfactory orientation and motor
movement are typically affected by manipulations of the

dopamine system (Adams et al.,

1985; Tran, Chowanadisai,

Lonnerdal, Parker, Chicz-DeMet,
et al.,

& Crinella, 2002; Vorhees

1995).

Consistent with prior research, the high dose of
manganese decreased weight gain during the neonatal period
(Dorman et al., 2000; Pappas et al.,

1996). This effect

dissipated with the cessation of manganese treatment,

because body weights of vehicle- and manganese-exposed rats
were similar on PD 23 and PD 91. Feeding behavior during

neonatal development is sensitive to manipulations of the
dopamine system, with both increased and decreased

dopaminergic transmission inducing anorexia

Campell, 1981; Zhou & Palmiter,

(Raskin &

1995). The anorexia

evidenced by rat pups in the current study is suggestive of
an increase in dopamine transmission because a high dose of
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manganese increases both striatal dopamine and DOPAC levels
(Dorman et al., 2000). Of course,

it remains possible that

the manganese-induced weight loss was mediated by nondopaminergic mechanisms.
Basal motor activity was not affected by neonatal

manganese exposure on PD 23 or PD 91. When challenged with

cocaine on PD 23, neither manganese treatment nor sex

impacted cocaine-induced behavior. However, when challenged
with 10 or 20 mg/kg cocaine on PD 91, male and female

manganese-exposed rats demonstrated a difference in the
response magnitude to cocaine. In particular,

female rats

had greater distance traveled scores than male rats after

being treated with either dose of cocaine. In fact,

female

rats treated with 10 mg/kg cocaine had distance traveled
scores that were similar to male rats treated with 20 mg/kg
cocaine. These data are consistent with previous reports

demonstrating that the efficacy of cocaine differs between

male and female rats. In particular, male rats require an

increased amount of cocaine to achieve the behavioral
intensity of female rats

(Festa et al., 2004).

Overall, early manganese exposure caused an atypical
response pattern to the locomotor activating effects of

cocaine in adulthood. Specifically, manganese was
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responsible for a pronounced reduction in the behavioral
response to cocaine. Similar findings have been reported in

rats exposed to manganese from gestation to PD 80 and then
challenged with amphetamine

(Leung et al.,

Several

1982).

explanations for these manganese-induced effects exist,
including 1)
2)

functional changes in postsynaptic receptors,

adaptive changes in the dopamine transporter,

and 3)

biphasic alterations in neurotransmitter levels.

The marked reduction in distance traveled scores of
manganese-exposed rats suggests that manganese causes long
term changes in the sensitivity of dopamine receptors. This
line of reasoning is primarily supported by studies

examining the effects of direct dopaminergic drugs on
postsynaptic terminals.

In particular, manganese decreases

the frequency and amplitude of quinpirole-induced

excitatory postsynaptic potentials,

suggesting a decreased

efficacy or decreased sensitivity of D2-like receptors
(Calabrassi et al., 2000). Additionally, manganese may

alter the functioning of Di-like dopamine receptors. The
attenuated motor activity observed in the present study

could be due to a dysfunction of the Di-like receptor,

because manganese decreases ligand binding to postsynaptic
Di-like receptors

(Eriksson, Gillberg, Aquilonius,
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Hedstrom,

& Heilbronn,

1992).

In the current study,

rats exposed to

750 pg manganese did not show the traditional dosedependant increase in cocaine-induced locomotor activity

that was apparent in control rats. In particular,

20 mg/kg

cocaine did not increase locomotor activity beyond that of
the 10 mg/kg cocaine group. It is possible that a

manganese-induced dysfunction of the Di-like receptor may
interfere with the enabling role that Di-like receptors play
in D2~like mediated behaviors. Specifically,

it is possible

that a manganese-induced subsensitivity of D2-like

receptors,

in combination with dysfunctional Di-like

receptors, may hamper the synergistic coupling of Di-like

and D2-like receptors during development.
A more parsimonious explanation for the attenuated

response to cocaine is that manganese caused neurotoxicity.

This hypothesis is supported by the finding that dopamine
transporter binding sites were reduced in rats exposed to
manganese

(750 pg)

from PD 1 - 21. Loss of dopamine

reuptake sites is indicative of damage to dopamine
terminals

(Frost & Cadet, 2000, Wagner, Ricaurte,

Schuster,

& Seiden,

Johanson,

1980). Most commonly, reductions in

dopamine transporters are associated with high doses of

psychostimulant drugs. A variety of environmental toxins,

135

including manganese, are also transported into the

intracellular environment via dopamine transporters, thus
leaving the neuron vulnerable to toxicity (Bridges &

Zalups, 2005; Erikson, Byron,

Montgomery,

& Aposhian,

& Beard, 2000;

1999; Miller et al.,

Ingersoll,

1999).

Alternatively, reductions in the number of dopamine

transporter binding sites may reflect functional changes,
including declined affinity. Conformational changes

structural changes)

(i.e.,

decrease the affinity of dopamine

transporters to cocaine and similar reuptake blockers
depending upon the affected transmembrane domain
Beuming,

Soyer, Goldstein, Weinstein,

Loland, Granas,

Nielsen,

Javitch,

& Javitch,

(Goldberg,

2003;

& Gether, 2004; Loland, Norgaard-

& Gether, 2003). For example, changes in structure

can alter the distribution of conformational states as well
as interfering with the "gating" mechanism between the

inter- and extracellular environment
Soyer, Goldstein, Weinstein,

(Goldberg, Beuming,

& Javitch, 2003). In regards

to the present experiment, manganese-exposed rats showed a

trend towards decreased affinity. Since manganese exposure
occurred during a sensitive period (i.e., PD 1 - 21)

for

the development of dopamine transporters

(Galineau et al.,

2004; Tarazi, Tomasini,

1998)

& Baldessaarini,
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it is

possible that the decline in affinity may result from
manganese-induced changes in the conformation of the

dopamine transporter. This possibility is unlikely,

however, because manganese has been shown to cause
neurotoxicity with prolonged exposure, while not
interfering with 3H-dopamine uptake in the striatum

(Defazio, Soleo, Zefferino, & Livrea, 1996) The latter
finding is important because 3H-dopamine uptake is a direct
indicator of the functionality of dopamine transporters.

In the current study, the pattern of behavioral

results is consistent with the biphasic progression of
manganese toxicity reported in neurochemical studies.
During the early stages of manganese poisoning, increases

in dopamine transmission have been reported (Dorman et al.,
2000; Seth & Chandra, 1984). In neonatal rats, manganese
exposure decreased [3H]-spiroperidol binding (Seth &

Chandra, 1984), which is consistent with reports of
manganese-induced increases in dopamine levels during the

neonatal period (Dorman et al., 2000; Seth & Chandra,
1984). As manganese toxicity progresses, damage to the

nigrostriatal pathway and the globus pallidus causes

behavioral abnormalities characteristic of manganese
poisoning. A dosing regimen of manganese, similar to the
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levels of manganese used in the current study,

caused a

reduction in striatal dopamine levels at PD 40 and 62
(Tran, Chowanadisai, Crinella, Chicz-DeMet,
2002; Tran, Chowanadisai, Lonnerdal, Le,
DeMet,

& Lonnerdal,

Parker, Chicz-

& Crinella, 2002). Thus, the manganese regimen used

in the present study is sufficient to cause long-term

depletions of striatal dopamine levels and a reduction in
dopamine transporter binding sites. When the present data
are combined together (i.e., the decreased body weights
during the neonatal period along with the pronounced

reduction in cocaine-induced behaviors on PD 91),

it

appears that exposing rats to 750 pg manganese on PD 1 - 21
is sufficient to induce the biphasic alterations in

dopamine transmission that are commonly associated with

manganese toxicity (Aschner, 2000; Chandra & Shulka,
Mergler,

1981;

1999).

In summary, the results of Experiment 2 are

consistent with previous studies showing that exposure to

manganese during the preweanling period causes lasting
alterations in cocaine-induced behaviors.

In addition,

weight gain and coordination were transiently affected by

manganese exposure. The behavioral changes observed in the

current experiment support the biphasic symptology
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evidenced during manganese toxicity. The behavioral effects
of manganese toxicity could be attributed to loss of

dopamine neurons, evidenced by decreased dopamine
transporters. Importantly, the levels of manganese used in

the current study are capable of causing long-term damage
to these membrane proteins, which may account for the

decreased locomotor activating effects of cocaine in

adulthood.
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CHAPTER TWELVE
EXPERIMENT THREE: THE EFFECTS OF NEONATAL
MANGANESE EXPOSURE ON COCAINE-INDUCED

CONDITIONED PLACE PREFERENCE

Methods

The purpose of Experiment 3 was to investigate the

effects of neonatal manganese treatment on drug reward by
utilizing a CPP paradigm.

It was hypothesized that neonatal

manganese exposure would reduce the rewarding properties of

cocaine, as evidenced by a decreased amount of time spent
in the drug-paired compartment.

Manganese Treatment

A total of 72 rats

(n = 8 per group) were used in this

experiment. On PD 1-21, rats were given daily supplements

consisting of 0, 250, or 750 pg manganese dissolved in 25 pi
of 10% sucrose solution.

Apparatus
Conditioned place preference was assessed in a T-

shaped plywood chamber that had three compartments

separated by removable partitions. The two end compartments

measured 24 x 30 x 45 cm high, while the offset compartment
measured 24 x 10 x 45 cm high. One end compartment had white
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walls, a wire mesh floor, and pine bedding beneath the

floor. The other end compartment had black walls, a metal

bar floor, and cedar bedding beneath the floor. The offset
compartment had gray walls and a solid wood floor. The

solid partitions could be replaced with partitions

containing 10 x 10 cm openings, which allowed rats free
access to the two end compartments.

Procedures
Following acclimation to handling, 90-day-old rats

from the three manganese conditions were placed in the
offset compartment (the start box) and allowed free access

to the two end compartments for 900 s. Initial compartment

preference was recorded.
On day 1 of conditioning, half of the rats were

restricted to the black compartment and half restricted to

the white compartment for 1800 s. Rats placed in the white
compartment were injected with cocaine (0, 10, or 20 mg/kg,

i.p.), whereas rats placed in the black compartment were
injected with saline. On day 2 of conditioning, rats were

restricted to the opposite compartment for 1800 s. Rats
previously injected with cocaine were given an injection of

saline, whereas rats previously given saline were injected
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with either 0, 10 or 20 mg/kg cocaine. Conditioning lasted

a total of 8 days with alternating daily placements in the
black and white compartments.
On the test day (i.e., day 9), rats were placed in the
offset compartment and allowed free access to the entire

apparatus for 900 s. Time spent in each chamber were
recorded.

Statistics
Separate between-subject 3x3x2 ANOVAs (manganese
condition x drug dose x sex) were used to analyze place

preference data. Initial preference day, acquisition test
day data, extinction test day data, and reinstatement data
were analyzed separetly. Post hoc comparisons were done

using Tukey tests (p < .05).

Results

Body Weights
Overall, manganese exposure caused a reduction in the

body weights of rat pups [manganese main effect,
F(2,62)=3.67, P < 0.05]. This effect was evident during the

later part of the manganese treatment phase, because rats
pretreated with 750 pg manganese weighed less than rats

pretreated with vehicle or 250 pg manganese on PD 13 - 21
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(Fig. 19)

[manganese x day interaction, F( 20, 620)=1.94, P <

0.05]. When measured on PD 91, body weights of adult rats
were not affected by neonatal manganese exposure. Not

surprisingly, adult male rats (384.40 g ± 4.25) weighed

significantly more than adult female rats (239.4 g ± 2.79)

[sex main effect, F(l,99)=844.36, P < 0.05].
Conditioned Place Preference: Conditioning,
Extinction and Reinstatement

Prior to conditioning, a preference for the black side

of the apparatus was apparent. This preference did not
differ according to manganese exposure or sex (Fig. 20). In
control animals, the black preference persisted throughout

acquisition, extinction and reinstatement.
On the conditioning test day, rats that received

cocaine showed a robust preference for the white (drugpaired) compartment (Fig. 21, upper right graph).

Specifically, conditioning with 10 or 20 mg/kg cocaine
caused an increase in time spent on the drug-paired side

relative to saline controls [cocaine main effect,

F(2,83)=45.84, P < 0.05]. The place preference for cocaine

disappeared by the extinction test day, because rats

conditioned with cocaine or saline spent similar amounts of
time in the white (drug-paired) compartment (Fig. 21, lower
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60

Figure 19. Mean (± S.E.M.) body weights of preweanling rats
(n = 22-24) treated from PD 1-21 with daily oral
supplements of manganese (250 or 750 pg) or vehicle.
aSignificant difference between rats treated with vehicle
and 750 pg manganese (P < 0.05).
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Figure 20.
Mean (± S.E.M.) time (s) spent in the white
compartment on the initial preference day (PD 90) for male
and female rats (n = 13-16) previously exposed to manganese
(250 or 750 pg) or vehicle from PD 1-21.
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Figure 21. Mean time spent (± S.E.M.) in the drug-paired
compartment on the Pre-Conditioning day, Conditioning,
Extinction, and Reinstatement test days. Rats (n = 27-33)
were initially given four alternating daily injections of
cocaine (10 or 20 mg/kg) or vehicle prior to placement on
the white side and four alternating injections of saline
prior to placement on the black side. During eight days of
extinction training, rats were injected with saline and
given alternating daily placement in the black and white
compartments. On the Reinstatement test day all rats were
primed with 20 mg/kg cocaine immediately prior to the
testing session. Rats were previously exposed to manganese
(250 or 750 pg) or vehicle from PD 1-21.
aIndicates a significant difference from rats conditioned
with saline (P < 0.05).

146

left graph). The cocaine-induced preference was reinstated
on the final test day. Overall, a priming dose of cocaine

reinstated a place preference in those rats originally

conditioned with either 10 or 20 mg/kg cocaine
lower right graph)

(Fig. 21,

[cocaine main effect, F(2,82)=18.7, P

<0.05].
There was no evidence that manganese caused any
alterations in the acguisition,

extinction, or

reinstatement of cocaine CPP (Fig. 22). Likewise,

sex did

not interact with manganese or cocaine to influence CPP.

Discussion: Experiment Three
Manganese accumulates in areas of the brain

(e.g.,

nucleus accumbens, prefrontal cortex, and globus pallidus)
associated with the rewarding properties of psychostimulant

drugs

(Berridge, 2003; Fell et al.,

Justice,

1996; 1997; Komaki et al.,

1996; Gong, Neill,

&

1999; McBride et al.,

1999; Panagis et al., 1997). However, it was unknown
whether exposure to manganese during neonatal development
would cause lasting changes in drug reward. For this
reason, the acquisition, extinction, and reinstatement of

cocaine-induced CPP was examined in male and female rats

exposed to manganese, from PD 1-21. Consistent with data
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Figure 22.
Mean time spent (± S.E.M.) in the drug-paired
compartment on the Conditioning, Extinction, and
Reinstatement test days. Rats (n = 9-12) were exposed to
manganese (250 or 750 pg) or vehicle from PD 1-21 and
conditioned with cocaine (0, 10, or 20 mg/kg) on four
alternating days. The place preference was extinguished
across eight daily sessions, and reinstated with a priming
dose of 20 mg/kg cocaine.
a Indicates a significant difference from rats conditioned
with saline (P < 0.05).
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from our laboratory (see Experiment. 2) and others (Dorman
et al., 2000; Pappas et al., 1996), rat pups treated with

750 pg manganese had reduced body weights during the later
part of

manganese treatment (PD 13-21). As expected, these

initial differences in body weight were not apparent prior

to the beginning of CPP conditioning (i.e., PD 90).
Originally, it was hypothesized that manganese exposure

would decrease the rewarding properties of cocaine. Male
and female rats in this study showed a robust preference
for the cocaine-paired side after the conditioning period,

and this preference was successfully extinguished and

reinstated with subsequent testing. However, there was no
indication that manganese treatment interfered with the

acquisition, extinction or reinstatement of cocaine CPP.

Male and female rats exhibited similar patterns of
responding through-out CPP acquisition, extinction and

reinstatement. Recently, it has been demonstrated that

gonadal hormones have a role in modulating the rewarding
effects of cocaine, thus causing an increased sensitivity

to the drug in female rats (Russo, Festa, Fabian, Gazi,
Kraish, Jenab, & Quinones-Jenab, 2003). However, this
effect primarily results from female rats, when compared to
male rats, showing place conditioning to lower amounts of
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the drug after fewer cocaine pairings

(Russo et al., 2003).

It has been reported that 10 mg/kg cocaine reliably induces

place preferences in both male and female rats, while 20
mg/kg cocaine may be the preferential dose for male rats

(Russo et al., 2003). In the present study,

20 mg/kg

cocaine produced robust CPP in both male and female rats.

Russo et al.

(2003) used a four-day conditioning period

whereas we used an eight-day conditioning procedure,
perhaps indicating that sex differences associated with

cocaine-induced CPP are dependant on fewer conditioning
sessions.

The current study shows that the CPP responding of

female rats, like male rats, can be extinguished and

reinstated with a priming dose of cocaine. This finding
indicates that male and female rats are capable of forming

associations between contextual stimuli and the rewarding

effects of cocaine, and that the salience of these

contextual cues can be extinguished and subsequently
reinstated with a priming injection of cocaine

(Mueller &

Stewart, 2000). These results are not consistent with
cocaine self-administration studies, which demonstrated
that female rats respond more robustly to a priming

injection of cocaine than male rats
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(Lynch & Carroll,

2000). In self-administration studies, however, rats are

required to engage in an operant response to obtain the
drug, while the CPP procedure relies on Pavlovian
associations formed between contextual stimuli and the
rewarding effects of the drug (i.e., an operant response is

not required). Moreover, in the former situation delivery
of the drug is controlled by the animal, whereas in the
latter situation drug administration is controlled by the
experimenter. Differences between drug-self administration

and CPP tasks may mean that separate neuronal mechanisms
underlie the reward processes associated with the two

behavioral paradigms (Bardo & Bevins, 2000). Therefore,
sex-differences observed in the reinstatement of cocaine

self-administration may be attributed to differences in the
reinforcing effects of cocaine; whereas, the similar

reinstatement patterns of male and female rats in a CPP

paradigm may indicate a lack of sex differences in those
mechanisms responsible for forming the association between
contextual stimuli and the rewarding properties of cocaine.

It is not known whether sex differences in the

reinstatement of cocaine CPP would emerge if a less optimal
CPP paradigm were used (i.e., fewer sessions or lower doses

of cocaine).
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Given recent reports demonstrating that environmental
neurotoxins can interfere with reward function (Guillot,
Richardson,

& Miller, 2004),

it is surprising that

manganese exposure did not impact the acquisition,
extinction, or reinstatement of cocaine-induced CPP. The
most likely explanation is that manganese differentially

affects the nigrostriatal and mesolimbic dopamine systems.

Although manganese accumulates in brain areas that make up
the mesolimbic dopamine system, manganese preferentially

damages dopamine neurons in the nigrostriatal pathway

(Eriksson, Lenngren,
Aschner,

& Heilbronn,

1987; Erikson,

& Aschner, 2002; Fell et al.,

Shihabi,

1996; Komaki et al.,

1999). Thus, the nigrostriatal system is more susceptible
to manganese toxicity than the mesolimbic reward system.

Alternatively, the dosing paradigm used in this experiment

may not have been sufficient to alter the mesolimbic
dopamine system. Behavioral manifestations of manganese

toxicity are dependant on age of exposure and testing,
route and dose of administration, and the biphasic

progression of toxicity (see Chapter 5). Therefore,

it is

unknown if a more aggressive manganese exposure paradigm
would interfere with reward system functioning.
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In conclusion, the findings of this experiment show
that neonatal manganese exposure did not impact the

acquisition, extinction,

or reinstatement of cocaine CPP.

However, manganese exposure from PD 1-21 did cause a
transient decrease in body weights during the neonatal

period. In addition, this experiment showed that place
preference to cocaine can be extinguished and later

reinstated in response to a priming dose of cocaine in
female rats as well as male rats. Experiment 3 also

demonstrated that sex differences are not observed when

cocaine-induced CPP is measured after an eight day
conditioning period (four cocaine pairings and four saline

pairings).
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CHAPTER THIRTEEN
GENERAL DISCUSSION

Manganese is a complex trace mineral that is an

essential nutrient but, at high levels, may also be a

neurotoxicant. It is generally believed that children and
infants may be at a particular risk for manganese
neurotoxicity due to an immature central nervous system

(Cawte,

1999).

1985; Mergler,

1999; Takada et al.,

1999; Weiss,

Importantly, infant formulas contain substantially

more manganese than the recommended daily allowance,

so

this sub-population of infants may be at particular risk
for developing lasting brain changes that result in long

term behavioral dysfunction

(Lonnerdal,

1994). There is

even evidence that the amount of manganese contained in

soy-based infant formula may be sufficient to induce brain

changes responsible for ADHD (Tran, Chowanadisai, Crinella,

Chicz-DeMet, & Lonnerdal, 2002; Tran, Chowanadisai,
Lonnerdal, Le, Parker, Chicz-DeMet,

& Crinella, 2002) .

Therefore, the purpose of this thesis was to examine the

effects of low to moderate doses of manganese

(0,

250, or

750 pg per day from PD 1-21) on a comprehensive battery of

behaviors that are sensitive to disruption of the dopamine
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system. The three experiments comprising this thesis

evaluated behavior during the neonatal period, preweanling
period, and adulthood.

Manganese exposure did not affect the appearance of
developmental landmarks, nor did it alter neonatal motor

activity or olfactory orientation. Manganese did, however,

impair neonatal motor coordination and depressed body
weight gain on PD 13-21. After cessation of manganese
treatment on PD 21, body weights returned to control levels
by PD 23. Importantly, manganese exposure did not affect

basal or cocaine-induced locomotor activity on PD 23. When
tested at PD 90, however, manganese-exposed rats exhibited

both reduced responding on a DRL 20 task and a pronounced
reduction in cocaine-induced motor activity. Early
manganes| exposure did not affect basal motor activity,

balance, or coordination at PD 90. Additionally, manganese

did not alter the rewarding properties of cocaine, as

measured by the acquisition, extinction, and reinstatement
of CPP.
When considered together, the present results suggest

that early manganese exposure causes a long-term
suppression in the initiation of motor movement, without
altering reward or learning processes. Manganese-induced
155

reductions in bar press responsivity are not likely due to

a learning impairment, because manganese did not interfere
with acquisition of either a response contingent behavioral

task (Experiment 1) or CPP (Experiment 3). These learning

paradigms differ because the former task requires the
performance of an overt voluntary behavior, while the later
task relies on the pairing of two previously unrelated
stimuli. Since manganese-induced deficits impacted the

execution of rapidly occurring bar press responses, and not
the learning of response contingencies, it is likely that
the behavioral differences were due to motor impairment.

Moreover, the inability of manganese to alter the
acquisition, extinction, and reinstatement of cocaineinduced CPP further suggests that learning mechanisms are

not affected by neonatal manganese exposure. However, it is
possible that manganese may cause learning impairments that

are not sensitive to the DRL or CPP paradigms.
The pronounced decrease in cocaine-induced locomotor

activity observed in manganese-exposed rats (Experiment 2)

is also consistent with a motor impairment hypothesis
rather than a reward hypothesis. This conclusion is

supported by the finding that early manganese exposure did
no't impact the acquisition, extinction, or reinstatement of
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cocaine CPP in adulthood (Experiment 3). Cocaine-induced

locomotor activity and CPP are mediated, at least
partially, by the mesocorticolimbic dopamine system (Bardo,

& Kelly, 1994; Mele, Thomas,

1998; Dickson, Lang, Hinton,

Pert,

1998; Wise & Bozarth,

&

1987). Motor movement, on the

other hand, is primarily mediated by the nigrostriatal

dopamine system, because damage to this system impairs
various indices of motoric function in both humans and

animals

(Arnt,

1987; Caine et al.,

1994; Carey,

Goldberg et al., 2003; Olanow et al.,

1996).

1986;

Importantly,

chronic manganese exposure causes cell loss in the

nigrostriatal pathway, which is characterized by

bradykinesia, dystonia, and widespread muscular rigidity
(Aschner, 2000; Caine et al.,

1994; Mergler,

1999).

Therefore, the most parsimonious conclusion is that early
manganese exposure causes motoric deficits that result from

dysfunction of the nigrostriatal dopaminergic system. In
particular, manganese-induced reductions in striatal

dopamine transporters is suggestive of neurotoxicity.
Motoric deficits are evidenced by decreased bar press

responding on a DRL schedule of reinforcement and
attenuation of psychostimulant-induced locomotor activity.
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Motor impairments observed in ADHD children involve
dopaminergic transmission in the nigrostriatal pathway
(Johansen et al., 2002; Sagvolden et al.,

1998). However,

manganese-induced motor impairments evidenced in this study
are not consistent with established rodent models of ADHD
(i.e.,

6-OHDA lesions,

PCB-exposed rats)

spontaneously hypertensive rats, and

(for a review,

see Davids,

& Baldessarini, 2003) . For example,
ADHD,

6-hydroxydopamine

(6-OHDA)

Zhang, Tarazi,

in one rodent model of

lesions are used to reduce

dopamine transporter binding in the striatum and nucleus

accumbens

(Davids, Zhang, Tarazi,

& Baldessarini, 2002).

These 6-OHDA-treated rats exhibit robust increases in basal
motor activity, that return to control levels with
methylphenidate treatment

(Davids et al., 2002). A second

rodent model of ADHD utilizes spontaneously hypertensive
rats. These rats display hyperactive behaviors consistent
with ADHD,

show decreased dopamine and serotonin turnover

in the striatum, and respond more quickly than controls to

an acute challenge of methylphenidate

(Amini, Yang,

Swann,

& Dafny, 2004; de Villiers, Russell, Sagvolden, Searson,
Jaffer,

Lamm,

& Taljaard,

1995; Russell, de Villiers,

Sagvolden,

& Taljaard, 2000). A third rodent model involves

exposing neonatal rats to PCBs. These rats show increased
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hyperactivity when compared to controls

Skaare,

& Sagvolden,

(Holene, Nafstad,

1998). In the present study,

manganese-exposed rats did not exhibit behaviors consistent
with established rodent models of ADHD. Specifically,

the

basal locomotor activity of manganese- and vehicle-exposed
rats was similar and manganese-treated rats showed a

lessened responsivity to cocaine. Manganese-exposed rats
also exhibited reduced bar pressing, bin 1 responses, and

burst responses. In contrast, both spontaneously
hypertensive rats and PCB-exposed rats exhibit an increase
in burst responses, which is suggestive of the impulsivity

associated with ADHD (Biox, Qiao, Kolpus,

1998; Holene et al.,

& Sagvolden,

1998). In summary, manganese-exposed

rats do not respond in a manner similar to the established
rodent models of ADHD.

Dysregulation of the dopamine system causes ADHD-type
symptomology. The dopamine transporter has been implicated
as a source of dysregulation by both genetic studies
et al.,

2001; Cook et al.,

Fitzgerald,

studies

1997; Waldman et al.,

& Farde, 2005; Krause,

Daly, Heron,

Fernell, Halidin,

Dresel, Krause,

la

& Ackenheil, 2003). Generally, neuroimaging
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Hawi,

1998) and neuroimaging

(Cheon et al., 2003; Jucaite,

Forssberg,
Fougere,

1995; Gill,

(Barr

&

studies show increased striatal dopamine transporters in

ADHD patients

(Krause et al., 2003; Cheon et al., 2003).

The expression of more dopamine transporters suggests

increased dopamine reuptake in ADHD cases. The result is a

decrease of extracellular dopamine concentrations that is

consistent with the dopamine hypothesis of ADHD (Swanson et
al., 2000). In rodent models,

spontaneously hypertensive

rats also show an increase in striatal dopamine

transporters

(Watanabe et al.,

1997). These findings are in

distinct contrast with the present study, in which I found

that early manganese exposure causes a persistent reduction
of dopamine transporters. Taken together, these findings

are consistent with the idea that neonatal manganese
exposure produces neurotoxicity that is unrelated to the

development of ADHD-type behaviors.

Although the results from this thesis suggest that
neonatal manganese exposure does not induce ADHD-type
symptoms, manganese does appear to have long-term

behavioral and neuronal consequences that are not expressed
until adulthood. Exposure to other neurotoxic substances

can also have long latency periods resulting in "silent"
damage

(Weiss, Clarkson,

& Simon, 2002). This is important

because pre-exposure to neurotoxicants may exacerbate or
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cause the early expression of neurodegenerative disorders

(i.e., Parkinson's Disease) that result from age-related
cell loss (Caine, Eisen, McGeer, & Spencer, 1986; Weiss,
Clarkson, & Simon, 2002). In the case of manganese

exposure, neurobehavioral and neuropsychiatric symptomology

are apparent long after blood levels and body burden of
manganese have returned to normal (Hochberg et al., 1996;

Huang et al., 1993; 1998). Moreover, neurological and

behavioral changes have been detected in humans exposed to
manganese even in the absence of overt symptoms of
manganese toxicity (Mergler, 1999).
In conclusion, this thesis demonstrates that exposure

to manganese during neonatal development causes both shortand long-term changes in behavior. Although, this thesis
does not provide data supporting a relationship between

early manganese exposure and ADHD, it does provide evidence
that manganese causes both long-term behavioral changes and

reductions in striatal dopamine transporters.
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